Cardiovascular medicine Books

Book SynopsisWhat drugs should be used to maintain someone in sinus rhythm who has paroxysmalatrial Fibrillation? How do I investigate the relatives of a patient with sudden cardiac death? Which cardiac patients should never get pregnant? This book answers these and other questions.Table of ContentsContributors. Introduction. 1. What are the cardiovascular risks of hypertension?. 2. Is 24 hour blood pressure monitoring necessary, and what do I do with the information?. 3. Who should be screened for a cause of secondary hypertension? How do I screen?. 4. What blood pressure should I treat, and what should I aim for when treating a 45 year old, a 60 year old, a 75 year old or an 85 year old?. 5. Is one treatment for hypertension proven to be better than another in terms of survival?. 6. It was once suggested that calcium channel blockers might be dangerous for treating hypertension. Is this still true?. 7. How can I outline a management plan for the patient with essential hypertension?. 8. How do I manage the patient with malignant hypertension?. 9. Which asymptomatic hypercholeterolaemic patients benefit from lipid-lowering therapy? What cholesterol level should I aim for?. 10.Which patients with coronary disease have been proven to benefit from pharmacological intervention? What lipid levels should I aim for?. 11.What drugs should I choose to treat dyslipidaemia, and how should I monitor treatment?. 12. What are the side effects of lipid-lowering therapy, and how should they be monitored?. 13. Is there a role for prescribing antioxidant vitamins to patients with coronary artery disease? If so, who should get them, and at what dose?. 14. What is the sensitivity, specificity and positive predictive value of an abnormal exercise test?. 15. What are the risks of exercise testing? What are the contraindications?. 16. What are the stratification data for risk from exercise tests in patients with angina? Which patterns of response warrant referral for angiography?. 17. Who should have a thallium scan? How does it compare with standard exercise tests in determining risk?. 18. What are hibernating and stunned myocardium? What echocardiographic techniques are useful for detecting them? How do these methods compare with others available?. 19. Which class of antianginal agent should I prescribe in stable angina? Does it matter?. 20. What is the role of troponin T in the diagnosis and risk stratification of acute coronary syndromes?. 21. What is the risks of myocardial infarction and death in someone with unstable angina during hospital admission, at six months and one year?. 22. What medical treatments of unstable angina are of proven benefit?. 23. Under what circumstances should the patient with unstable angina undergo PTCA or CABG?. 24. What new approaches are there to prevent restenosis following PTCA?. 25. Which thrombolytics are currently available for treating acute myocardial infrarction? Who should receive which one? What newer agents are there?. 26. Is angioplasty better than thrombolysis in myocardial infarction? Which patients should receive primary or "hot" angioplasty for these conditions?. 27. Whar are the contraindication to thrombolytic therapy for acute myocardial infarction? Is diabetic retinopathy a contraindication?. 28. Exercise testing after myocardial infarction: how soon, what protocol, how should results be acted upon?. 29. What are the risks of recurrent ischaemic events after myocardial infarction: prehospital, at 30 days and at 1 year?. 30. What is appropriate secondary prevention after acute myocardial infarction?. 31. What advice should I give patients about driving and flying after myocardial infarction?. 32. What is the mortality rate for cardiogenic shock complicating myocardial infarction? How should such patients be managed to improve outcome and what are the results?. 33. What is the risk of a patient dying or having a myocardial infarction around the time of surgery for coronary artery disease and for valve replacements?. 34. Which patients with post-infarct septal rupture should be treated surgically, and what are the success rates?. 35. What patterns of coronary disease are associated with improved short and long term survival after CABG compared with medical therapy?. 36. Coronary artery bypass grafting: what is the case for total arterial revascularization?. 37. How common are neuropsychological complications after cardiopulmonary bypass (CPB)? How predictable are severe are they? Can they be prevented?. 38. Are there benefits to switching from sulphonylureas to insulin after coronary artery bypass grafting?. 39. How does recent myocardial infarction affect the perioperative risks of coronary artery bypass grafting?. 40. How soon before cardiac surgery should aspirin be stopped?. 41. When should we operate to relieve mitral regurgitation?. 42. When to repair the miral valve?. 43. What is the Ross procedure? When is it indicated and what are the advantages?. 44. What is the risk of stroke each year after a) tissue or b) mechanical MVR or AVR? What is the annual risk of bacterial endocarditis on these prosthetic valves?. 45. When and how should a ventricular septal defect be closed in adults?. 46. How should I treat atrial septal defects in adults?. 47. How do I follow up a patient who has had correction of aortic coarctation? What should I look for and how should they be managed?. 48. How should I investigate a patient with hypertrophic cardiomyopathy (HCM)?. 49. What is the medical therapy for patients with hypertrophic cardiomyopathy, and what surgical options are of use?. 50. What is the role of permanent pacing in hypertrophic cardiomyopathy?. 51. How do I investigate protocol should a patient with hypertrophic cardiomyopathy? How should they be followed?. 52. What investigation protocol should a patient with dilated cardiomyopathy undergo?. 53. Which patients with impaired ventricles should receive an ACE inhibitor? We are the survival advantages? Do ATI-receptor antagonist confer the small advantages?. 54. What is the role of vasodilators in the chronic heart failure? Who should receive them?. 55. Should I give digoxin to patients with heart failure if they have sinus rhythm? If so, to whom? Are there dangers to stopping it once started?. 56. Which patient with heart failure should have a beta blocker? How do I start it and how should I monitor therapy?. 57. What is mean and model life expectancy in NYHA I-IV heart failure?. 58. What are LVADs and BIVADS, who should have them?. 59. Who is eligible heart or heart-lunging transplant? How do I assess suitability for transplantation?. 60. What are the survival figures for the heart and heart-lunging transplantation?. 61. What drugs do post-transplant patients require, and what are there side effects? How should I follow up such patients?. 62. Can a cardiac transplant patient get angina? How is this investigated?. 63. What drugs should be used to maintain someone in sinus rhythm who has paroxysmal atrial fibrillation? Is there a role for digoxin?. 64. Which patients with paroxysmal or chronic atrial fibrillation should I treat with aspirin, warfarin or neither?. 65. Which patients with SVT should be referred for an intracardiac electrophysiological study (EP study)? What are the success rates and risks of radiofrequency (RF) ablation?. 66. What drugs should I use for chemically cardioverting atrial fibrillation and when is DC cardioversion preferable?. 67. How long should someone with atrial fibrillation be anticoagulated before DC cadioversion, and how long should this be continued afterwards?. 68. What factors determine the chances of successful elective cardioversion from atrial fibrillation?. 69. What are the risks of elective DC cardioversion from atrial fibrillation?. 70. Are patients with atrial flutter at risk of embolisation when cardioverted? Do they need anticoagulation to cover the procedure?. 71. How do I assess the risk of CVA or TIA in a patient with chronic atrial fibrillation?. 72. How sensitive are transthoracic and transoesophageal echocardiography for the detection of thrombus in the left atrium?. 73. What are the roles of transthoracic and transoesophageal echocardiography in patients with a TIA or stroke?. 74. Which patient with a patent foramen ovale should be referred for closure?. 75. How should I investigate the patient with collapse? Who should have a tilt test, and what do I do if it is positive?. 76. What are the chances of a 24 hour tape detecting the causes for collapse in a patient? What other alternative monitoring devices are now available?. 77. Should the patient with trifascicular disease be routinely paced? If not, why not?. 78. Who should have VVI pacemakers and who should have dual chamber pacemakers? What are the risks of pacemaker insertion?. 79. Can a patient with a pacemaker touch an electric fence? …have an MRI scan? …go through airport metal detectors? …use a mobile phone?. 80. What do I do if a patient has a pacemaker and needs cardioversion?. 81. What do I do about non-sustained ventricular tachycardia on a 24 hour tape?. 82. How do I treat torsades de pointers at a cardiac arrest?. 83. How do I assess the patient with long QT? Should I screen relatives, and how? How do I treat them?. 84. How do I investigate the relatives of a patient with sudden cardiac death?. 85. What percentage of patients will suffer the complications of amiodarone therapy, and how reversible are the eye, lung, and liver changes? How do I assess thyroid function in someone on amiodarone therapy?. 86. Who should have a VT stimulation study? What are the risks and benefits?. 87. What are the indications for implantable cardioverter defibrillator (ICD) implantation and what are the survival benefits?. 88. How do I manage the patient with an ICD?. 89. How do I follow up the patient with the implantable cardioverter defibrillator?. 90. What do I do if an ICD keeps discharging?. 91. How do I manage the pregnant woman with dilated cardiomyopathy?. 92. How do I manage the pregnant woman with valve disease?. 93. Which cardiac patients should never get pregnant? Which cardiac patients should undergo elective Caesarean section?. 94. A patient is on life-long warfarin and wishes to become pregnant. How should she be managed?. 95. How should the anticoagulation of a patient with a mechanical heart valve be managed for elective surgery?. 96. What are the indications for surgical management of endocarditis?. 97. What is the morbidity and mortality of endocarditis with modern day management (and how many relapse)?. 98. What percentage of blood cultures will be positive in endocarditis?. 99. Which patients should receive antibiotic prophylaxis for endocarditis, and which procedures should be covered in this way?. 100. Which patients should undergo preoperative non-invasive investigations or coronary angiography?. 101. Which factors predict cardiac risk from general surgery and what is the magnitude of the risks associated with each factor?. Index.. . .

Read more less

Book SynopsisInspiration for the Emmy Award-winning HBO film Something the Lord Made and the award-winning PBS documentary Partners of the Heart.Trade Review"The fascinating tale of an extraordinary black man's involvement, growth, and final recognition in a white man's world of surgical research and medical practice. . . . At the same time, an insightful firsthand account of the genesis of some of the pioneering research into the nature of shock and some of the early procedures in cardiovascular surgery." * Journal of the History of Medicine *"For one who had the privilege of being a student, coworker, and later a colleague of Vivien Thomas, reading this autobiography is an extraordinary experience. Although the reviewer worked with him in the laboratory for 20 years, often on a daily basis, many features of this unique and compelling story have been revealed for the first time." * David C. Sabiston, Journal of the American Medical Association *Table of ContentsForeword by Mark M. Ravitch, M.D. Preface Acknowledgements PART ONE. THE VANDERBILT YEARS PART TWO. THE HOPKINS YEARS PART THREE. RECOGNITION References Name Index Subject Index

Read more less

Book SynopsisThis book addresses consequences on the cardiovascular system that arise from iatrogenesis— the occurrence of untoward effects resulting from actions of health care providers, including medical errors, medical malpractice, practicing beyond one’s expertise, adverse effects of medication, unnecessary treatment, inappropriate screenings, and surgical errors.Table of ContentsTABLE OF CONTENTS Part I: MEDICAL HARM 1. The Concept and Spectrum of "Iatrogenicity" I. Gussak and J. Kostis 2. Iatrogenicity: Definition, History and Modern Context M. Gussak, I. Gussak, and J. Kostis 3. Epidemiology and Public Health Aspects and Implications: Regulatory, Legal and Ethical Dimensions of Iatrogenicity S. Jones and M. Gonzalez 4. Risk Management: The Medical Center Administration Perspective S. Jones and M. Gonzalez 5. Iatrogenicity from the Patient's Perspective J. Dobrzynski, S. Jones, and M. Gonzalez 6. A Naturopathic Perspective on Iatrogenesis C. Fleetwood Part II: IATROGENICITY OF CARDIOVASCULAR DURGS AND CARDIOVASCULAR TOXICITY OF NON-CARDIAC DRUGS 7. Clinical Manifestations of Acute and Chronic Drug-Induced Iatrogenic Cardiovascular Diseases and Syndromes I. Gussak, G. Yan, A. Jahangir, and J. Kostis 8. Drug-Induced Cardiac Arrhythmias and Sudden Cardiac Death A. Narichania, Y. Yokoyama, and W.K. Shen 9. Chemotherapy-Induced Cardiomyopathies E. Birati and B. Jessup 10. Iatrogenicity of Blood Pressure Mesaurement in the Diagnosis of Hypertension T. Giles, G. Sander, I. Gussak, and J. Kostis 11. Antihypertensive Drug-Induced Iatrogenic Cardiovascular Syndromes R. Kalaitzidis and G. Bakris 12. Iatrogenicity of Cardiovascular Drugs Associated with Cardiac and Non-Cardiac Toxicities: Antihypertensive Agents and Biologics E. Hermes-Desantis and J. Barone 13. Iatrogenic Aspects of Hypertension in Pregnancy: Focus on Preeclampsia C. Thomopoulos and T. Makris 14. Women and Iatrogenic Cardiovascular Disease: Menopausal Estrogen as the Prime Suspect G. Bachmann, M. Rees, and N. Phillips 15. Iatrogenic Aspects of Lipid-Lowering Agents, Thrombolytic, Antiplatelet, and Antithrombotic Agents C. Tsioufis, D. Konstantinidis, N. Vogiatzakis, and K. Dimitriadis 16. Iatrogenic Effects of ‘Urologic' Drugs on the Cardiovascular System K. Stavropoulos, C. Boutari, K. Imprialos, and M. Doumas 17. Iatrogencity and Antianginal Drugs A. Moreyra and W.J. Kostis 18. Anti-Diabetic Drugs and Cardiovascular Risk: Where Do We Stand? R. Kumar 19. Cardiovascular Iatrogenicity in Older Adults A. Khan, #. Ali, #. Iyengar, #. Hagiwara, #. Periyakoil, #. Patel, #. Malone Part III: IATROGENCITY OF DIAGNOSTIC AND THERAPEUTIC, INVASIVE AND NON-INVASIVE CARDIOVASCULAR INTERVENTION, DEVICES, AND SURGERIES 20. Iatrogenic Aspects of Non-Invasive and Invasive Diagnostic Methods in Interventional Cardiology C. Dösch, D. Loßnitzer, T. Papavassiliu 21. Iatrogenicity Associated with Interventional Treatment Modalities N.V. Pothineni, A. Garg, H. Paydak, and J.L. Mehta 22. Iatrogenicity of Diagnostic and Therapeutic, Invasive and Non-Invasive Cardiovascular Interventions, Devices and Surgeries M. Behnes, T. Becher, S. Baumann, and I. Akin 23. Iatrogenic Aspects in Cardiac Electrophysiology B. Rudic, E. Tülümen, and V. Liebe 24. Iatrogenic Aspects in Cardiac Device Therapy S. Röger and J. Kuschyk 25. Cardiovascular Iatrogencity of Respiratory Therapeutic Modalities M.S. Nolledo, P. Lerma and T.V. Santiago Part IV: IATROGENIC ASPECTS OF SPORT CARDIOLOGY AND LIFE-STYLE MODIFICATIONS 26. Professional Athletes G. Mancia 27. Sports Cardiology G. Campanile 28. Dangers of Lifestyle Modification Advice G. Campanile Part V: IATROGENICITY OF DIETARY SUPPLEMENTS, HERBAL PRODUCTS, AND OTHER NON-TRADITIONAL THERAPIES IN CARDIOVASCULAR MEDICINE 29. Safety of Over-the-Counter ‘Natural Substances’ and Vitamins: Side-effects and Contraindications S. Sultan, A. Jahangir, C. Ding, H. Cao, J.B. Kostis, I.B. Gussak, and A. Jahangir 30. Interactions Between Supplements and Prescription Medications S. Sultan, A. Jahangir, C. Ding, H. Cao, J.B. Kostis, I.B. Gussak, and A. Jahangir Acknowledgments Index

Read more less

Book SynopsisThis book addresses consequences on the cardiovascular system that arise from iatrogenesis— the occurrence of untoward effects resulting from actions of health care providers, including medical errors, medical malpractice, practicing beyond one’s expertise, adverse effects of medication, unnecessary treatment, inappropriate screenings, and surgical errors.Table of ContentsTABLE OF CONTENTS Part I: MEDICAL HARM 1. The Concept and Spectrum of "Iatrogenicity" I. Gussak and J. Kostis 2. Iatrogenicity: Definition, History and Modern Context M. Gussak, I. Gussak, and J. Kostis 3. Epidemiology and Public Health Aspects and Implications: Regulatory, Legal and Ethical Dimensions of Iatrogenicity S. Jones and M. Gonzalez 4. Risk Management: The Medical Center Administration Perspective S. Jones and M. Gonzalez 5. Iatrogenicity from the Patient's Perspective J. Dobrzynski, S. Jones, and M. Gonzalez 6. A Naturopathic Perspective on Iatrogenesis C. Fleetwood Part II: IATROGENICITY OF CARDIOVASCULAR DURGS AND CARDIOVASCULAR TOXICITY OF NON-CARDIAC DRUGS 7. Clinical Manifestations of Acute and Chronic Drug-Induced Iatrogenic Cardiovascular Diseases and Syndromes I. Gussak, G. Yan, A. Jahangir, and J. Kostis 8. Drug-Induced Cardiac Arrhythmias and Sudden Cardiac Death A. Narichania, Y. Yokoyama, and W.K. Shen 9. Chemotherapy-Induced Cardiomyopathies E. Birati and B. Jessup 10. Iatrogenicity of Blood Pressure Mesaurement in the Diagnosis of Hypertension T. Giles, G. Sander, I. Gussak, and J. Kostis 11. Antihypertensive Drug-Induced Iatrogenic Cardiovascular Syndromes R. Kalaitzidis and G. Bakris 12. Iatrogenicity of Cardiovascular Drugs Associated with Cardiac and Non-Cardiac Toxicities: Antihypertensive Agents and Biologics E. Hermes-Desantis and J. Barone 13. Iatrogenic Aspects of Hypertension in Pregnancy: Focus on Preeclampsia C. Thomopoulos and T. Makris 14. Women and Iatrogenic Cardiovascular Disease: Menopausal Estrogen as the Prime Suspect G. Bachmann, M. Rees, and N. Phillips 15. Iatrogenic Aspects of Lipid-Lowering Agents, Thrombolytic, Antiplatelet, and Antithrombotic Agents C. Tsioufis, D. Konstantinidis, N. Vogiatzakis, and K. Dimitriadis 16. Iatrogenic Effects of ‘Urologic' Drugs on the Cardiovascular System K. Stavropoulos, C. Boutari, K. Imprialos, and M. Doumas 17. Iatrogencity and Antianginal Drugs A. Moreyra and W.J. Kostis 18. Anti-Diabetic Drugs and Cardiovascular Risk: Where Do We Stand? R. Kumar 19. Cardiovascular Iatrogenicity in Older Adults A. Khan, #. Ali, #. Iyengar, #. Hagiwara, #. Periyakoil, #. Patel, #. Malone Part III: IATROGENCITY OF DIAGNOSTIC AND THERAPEUTIC, INVASIVE AND NON-INVASIVE CARDIOVASCULAR INTERVENTION, DEVICES, AND SURGERIES 20. Iatrogenic Aspects of Non-Invasive and Invasive Diagnostic Methods in Interventional Cardiology C. Dösch, D. Loßnitzer, T. Papavassiliu 21. Iatrogenicity Associated with Interventional Treatment Modalities N.V. Pothineni, A. Garg, H. Paydak, and J.L. Mehta 22. Iatrogenicity of Diagnostic and Therapeutic, Invasive and Non-Invasive Cardiovascular Interventions, Devices and Surgeries M. Behnes, T. Becher, S. Baumann, and I. Akin 23. Iatrogenic Aspects in Cardiac Electrophysiology B. Rudic, E. Tülümen, and V. Liebe 24. Iatrogenic Aspects in Cardiac Device Therapy S. Röger and J. Kuschyk 25. Cardiovascular Iatrogencity of Respiratory Therapeutic Modalities M.S. Nolledo, P. Lerma and T.V. Santiago Part IV: IATROGENIC ASPECTS OF SPORT CARDIOLOGY AND LIFE-STYLE MODIFICATIONS 26. Professional Athletes G. Mancia 27. Sports Cardiology G. Campanile 28. Dangers of Lifestyle Modification Advice G. Campanile Part V: IATROGENICITY OF DIETARY SUPPLEMENTS, HERBAL PRODUCTS, AND OTHER NON-TRADITIONAL THERAPIES IN CARDIOVASCULAR MEDICINE 29. Safety of Over-the-Counter ‘Natural Substances’ and Vitamins: Side-effects and Contraindications S. Sultan, A. Jahangir, C. Ding, H. Cao, J.B. Kostis, I.B. Gussak, and A. Jahangir 30. Interactions Between Supplements and Prescription Medications S. Sultan, A. Jahangir, C. Ding, H. Cao, J.B. Kostis, I.B. Gussak, and A. Jahangir Acknowledgments Index

Read more less

Book SynopsisStroke is the fourth leading cause of death in the United States. Despite the frequency and morbidity of stroke, there is a relative paucity of “stroke experts” for these patients. Ischemic Stroke closes the gap in stroke care by providing a cogent and intuitive guide for all physicians caring for stroke patients.Table of ContentsTABLE OF CONTENTS 1 Emergent Evaluation of the Suspected Stroke Patient 2 Clinical Signs and Symptoms of Stroke 3 Mechanisms of Ischemic Stroke 4 Neuroimaging of Acute Stroke 5 Cardiac-Based Evaluation of Ischemic Stroke 6 Thrombolytic Therapy for Acute Ischemic Stroke 7 Endovascular Management of Acute Ischemic Stroke 8 Critical Care Management of Ischemic Stroke 9 Stroke Rehabilitation 10 Cardiac Arrhythmias and Stroke 11 Secondary Prevention of Cardiogenic Stroke 12 Treatment of Symptomatic Carotid Stenosis 13 Intracranial Large Vessel Disease 14 Small Vessel Disease 15 Cryptogenic Stroke Index

Read more less

Book SynopsisIn the course of understanding the mechanism and therapy of atrial tachycardia, important distinctions are emerging in electrophysical evaluations of various atrial arrhythmias. This is a review of the latest knowledge in the field.Table of ContentsIntroduction. II. Definitions. III. Electrophysiologic Mechanisms. 1. Reentry. 2. Abnormal Automaticity. 3. Triggered Activity. IV. Focal Atrial Tachycardia. 1. Clinical and Electrocardiographic Presentation. The Role of P Wave Configuration. Tachycardia-Induced Cardiomyopathy. Multifocal Atrial Tachycardia. 2. Electrophysiologic Characteristics and Diagnosis. 3. Therapy. The Role of Newer Technologies for Mapping and Ablation of Atrial Tachycardia. The Role of Atrial Anatomy. V. Atrial Fibrillation as a Manifestation of Focal Atrial Activation. 1. Clinical and Electrocardiographic Presentation. 2. Electrophysiologic Characteristics and Diagnosis. 3. Therapy. VI. Incisional Intraatrial Reentrant Tachycardia. 1. Clinical and Electrocardiographic Presentation. 2. Electrophysiologic Characteristics and Diagnosis. 3. Therapy. VII. Inappropriate Sinus Tachycardia. 1. Clinical and Electrocardiographic Presentation. 2. Electrophysiologic Characteristics and Diagnosis. 3. Therapy. VIII. Conclusion. References. Index.

Read more less

Book SynopsisIn this book Dr Edwards shares his vast experience in a discussion of the fundamental anatomy and physiology associated with congenital heart disease. The text provides succinct descriptions of the common and uncommon abnormalities of congenital heart disease and the principles underlying their treatment, while 200 figures clearly demonstrate and guide the user to understand the essential nature of the characteristic defects and abnormalities discussed.Table of ContentsAcknowledgements. Foreword. Guest Preface. Preface. Recollections. Abbreviations. Variations of Bodily Organs. Atrial Anomalies. Ventricular Anomalies. Atrioventricular Cushion Defect. Myocardial Disease. Single Ventricle. Complete Transposition. Corrected Transposition. Double Outlet Right Ventricle. Tetralogy of Fallot. Anomalies of Pulmonary Arteries. Persistent Truncus Arteriosus. Anomalies of Coronary Vessels. Valvular and Related Anomalies. Aortic Atresia. Pulmonary Atresia. Mitral Atresia. Tricuspid Atresia. Aortic Stenosis. Subaortic Stenosis. Pulmonary Stenosis. Mitral Stenosis and Similar Functional Entities. Aortic Regurgitation. Pulmonary Regurgitation. Mitral Regurgitation. Tricuspid Dysplasia and Regurgitation in Ebstein's Malformation. Patent Ductus Arteriosis and AP Window. Aortic Sinus Aneurysm. Aortic Coarctation. Supravalvular Aortic Stenosis. Hypoplasia or Interruption of the Aortic Arch. Vascular Rings and Vascular Slings. Anomalies of Pulmonary Veins. Vena Caval Systems. Asplenia and Polysplenia. References. Index

Read more less

Book SynopsisPractical Management of Pediatric Cardiac Arrhythmias offers a useful source of current, practical information on the diagnosis and management of arrhythmias in children, and is intended for all caregivers, from novice to expert, who treat children, adolescents, and young adults with arrhythmias.Trade Review"The book serves as a useful source of current information and practical data regarding the diagnosis and management of pediatric arrhythmias and appeals to all aspects of caregiving. "Much of the book could serve as a nursing care manual. The approach is succinct and practical, deemphasizing electrophysiology basic science. "This is a valuable, practical addition to a field of medicine which is sometimes obscure. The book is very useful for the practicing nurse or physician." --Doody’s Review Service "I applaud the authors for their well-demonstrated effort to remember that treating the whole person in pediatrics means treating the whole family. Each of these sections not only reminds the clinician of the educational and emotional needs of the family of a child with a newly diagnosed arrhythmia, but also suggests strategies for promoting acceptance, understanding, and compliance. Overall, this book is an important addition to the library of any clinician who is involved in the care of a child with cardiac arrhythmias." --Critical Care NurseTable of ContentsForeword. Thomas P. Graham, Jr., MD. Chapter 1. Mechanisms, Diagnostic Tools, and Patient and Family Education. Vicki L. Zeigler, RN, MSN, Dianne Marlow, RN, BSN, CLNC and Paul C. Gillette, MD. Chapter 2. Supraventricular Arrhythmias. Sarah S. LeRoy RN, MSN, CPNP and Macdonald Dick II, MD. Chapter 3. Ventricular Arrhythmias. Vicki L. Zeigler, RN, MSN and Paul C. Gillette, MD. Chapter 4. Immediate Arrhythmia Management. Barbara J. Knick, RN, CVT and J. Phillip Saul, MD. Chapter 5. Long-Term Antiarrhythmic Drug Therapy. Debra G. Hanisch, RN, MSN, CPNP and George F. Van Hare, MD. Chapter 6. Radiofrequency Catheter Ablation. Dianne Marlow, RN, BSN, CLNC and Paul C. Gillette, MD. Chapter 7. Permanent Pacemakers. Sherry J. Taylor, RN, BSN, Vicki L. Zeigler, RN, MSN, and John M. Clark, MD. Chapter 8. Implantable Cardioverter Defibrillators. Vicki L. Zeigler, RN, MSN, Karen Corbett, PhD, RN, Ann Lewis, RN, BSN, and Paul C. Gillette, MD. Index

Read more less

Book SynopsisIntroduces the knowledge and skills needed to analyze symptoms, physical findings, and ECG and x-ray abnormalities in order to accurately diagnose more than 50 different conditions that may bring about a complaint of 'chest pain'. This book concentrates on causative syndromes or maladies, from its initial presentation to its etiology.Trade Review"This book...is worth owning. It is not going out of date next year!" William C. Roberts American Journal of CardiologyTable of ContentsPreface. Chapter 1. An Explanation of the Title and General Comments. J. Willis Hurst, M.D. PART I: Skin Disease as a Cause for "Chest Pain". Chapter 2. "Chest Pain" in Patients with Herpes Zoster (Shingles). Calvin O. McCall, M.D. and S. Wright Caughman, M.D.. PART II: Musculoskeletal Diseases as a Cause for "Chest Pain". Chapter 3. "Chest Pain" in Patients with Costochondritis or Tietze's Syndrome. Byron R. Williams, M.D.. Chapter 4. "Chest Pain" in Patients with Thoracic Outlet Syndromes. Vinod H. Thourani, M.D. and Joseph I. Miller, Jr., M.D.. Chapter 5. "Chest Pain" in Patients with Chest Wall Syndromes. J. Willis Hurst, M.D. Chapter 6. "Chest Pain" in Patients with the Shoulder-Hand Syndrome. Mark E. Silverman, M.D.. Chapter 7. "Chest Pain" in Patients with Bursitis of the Shoulder. Stephen B. Miller, M.D. Chapter 8. "Chest Pain" in Patients with Rotator Cuff Tendonitis or Arthritis of the Shoulder. Andrew P. Gutow, M.D. Chapter 9. "Chest Pain" in Patients with Joint Disease of the Cervical or Thoracic Spine. Stephen B. Miller, M.D.. PART III: Thrombophlebitis as a Cause for "Chest Pain". Chapter 10. "Chest Pain" in Patients with Mondor's Syndrome. Stephen D. Clements, Jr., M.D.. PART IV: Neurologic Disease as a Cause for "Chest Pain". Chapter 11. "Chest Pain" in Patients with Cervical Disc Syndromes. David J. Hewitt, M.D. Chapter 12. "Chest Pain" in Patients with Brachial Plexus Neuropathy. David J. Hewitt, M.D. PART V: Mediastinal Disease as a Cause for "Chest Pain". Chapter 13. "Chest Pain" in Patients with Mediastinal Emphysema. Talmadge E. King, Jr., M.D. PART VI: Pulmonary Causes of "Chest Pain". Chapter 14. "Chest Pain" in Patients with Pleuritis. Talmadge E. King, Jr., M.D.. Chapter 15. "Chest Pain" in Patients with Pneumothorax. Talmadge E. King, Jr., M.D.. Chapter 16. "Chest Pain" in Patients with Pulmonary Embolism. Nanette K. Wenger, M.D. Chapter 17. "Chest Pain" in Patients with "Café" Coronary. Stephen D. Clements, Jr., M.D. PART VII: Diseases of the Gastrointestinal Tract as a Cause for "Chest Pain". Chapter 18. "Chest Pain" in Patients with Esophageal Motility Disorders. J. Patrick Waring, M.D. Chapter 19. "Chest Pain" in Patients with Gastroesophageal Reflux. J. Patrick Waring, M.D. Chapter 20. "Chest Pain" in Patients with Esophageal Rupture. J. Patrick Waring, M.D. Chapter 21. "Chest Pain" in Patients with Esophageal Stenosis. J. Patrick Waring, M.D. Chapter 22. "Chest Pain" in Patients with Pill-Induced Esophagitis. J. Patrick Waring, M.D. Chapter 23. "Chest Pain" of Esophageal Origin in Patients with HIV. J. Patrick Waring, M.D.. Chapter 24. "Chest Pain" in Patients with Peptic Ulcer Disease. Steve Goldschmid, M.D. PART VIII: Diseases of the Gallbladder and Biliary Tract as Causes of "Chest Pain". Chapter 25. "Chest Pain" in Patients with Biliary Colic. Steve Goldschmid, M.D. Chapter 26. "Chest Pain" in Patients with Acute Cholecystitis. Steve Goldschmid, M.D. PART IX: Pericardial Disease as a Cause for "Chest Pain". Chapter 27. "Chest Pain" in Patients with Acute Pericarditis. David H. Spodick, MD, DSc. PART X: Heart Disease as a Cause for "Chest Pain". Chapter 28. "Chest Pain" in Patients with Cardiac Arrhythmias. Paul F. Walter, M.D. and J. Willis Hurst, M.D.. Chapter 29. "Chest Pain" in Patients with Angina Pectoris. J. Willis Hurst, M.D. Chapter 30. "Chest Pain" in Patients with Myocardial Infarction. Douglas C. Morris, M.D. Chapter 31. "Chest Pain" in Patients with Prinzmetal''s Angina. David Waters, M.D. and Rabih R. Azar, M.D., M.Sc. Chapter 32. "Chest Pain" in Patients with Myocardial Infarction with Normal or Near Normal Coronary Arteriogram. Rabih R. Azar, M.D., M.Sc. and David Waters, M.D.. Chapter 33. "Chest Pain" in Patients Who Use Cocaine. Jessica Haberer, M.D. and David Waters, M.D.. Chapter 34. "Chest Pain" in Patients with Congenital Heart Disease. Joseph K. Perloff, M.D.. Chapter 35. "Chest Pain" in Patients with Aortic Valve Stenosis. Douglas C. Morris, M.D. Chapter 36. "Chest Pain" in Patients with Aortic Valve Regurgitation. Douglas C. Morris, M.D. Chapter 37. "Chest Pain" in Patients with Rheumatic Mitral Valve Stenosis. Douglas C. Morris, M.D. Chapter 38. "Chest Pain" in Patients with Hypertrophic Cardiomyopathy. Douglas C. Morris, M.D.. Chapter 39. "Chest Pain" in Patients with Dilated Cardiomyopathy. Douglas C. Morris, M.D. Chapter 40. "Chest Pain" in Patients with Restrictive Cardiomyopathy. Douglas C. Morris, M.D. Chapter 41. "Chest Pain" in Patients with Pulmonary Hypertension. Robert C. Schlant, M.D. Chapter 42. "Chest Pain" in Patients with Systemic Hypertension. J. Willis Hurst, M.D. PART XI: "Chest Pain" Caused by Diseases of the Aorta. Chapter 43. "Chest Pain" in Patients with Aortic Dissection. Joseph Lindsay, Jr., M.D. Chapter 44. "Chest Pain" in Patients with Aortic Aneurysms. Joseph Lindsay, Jr., M.D. PART XII: "Chest Pain" Related to Emotional or Psychiatric Conditions. Chapter 45. "Chest Pain" in Patients with Anxiety Disorders. Bernard L. Frankel, M.D.. Chapter 46. "Chest Pain" in Patients with Depressive Disorders. Bernard L. Frankel, M.D.. Chapter 47. "Chest Pain" in Patients Who Are Malingering. James C. Hamilton, Ph.D. and Marc D. Feldman, M.D.. Chapter 48. "Chest Pain" in Patients with Factitious Disorder Including Munchausen Syndrome. Marc D. Feldman, M.D. and James C. Hamilton, Ph.D.. Chapter 49. "Chest Pain" in Patients with Addiction. Karen Drexler, M.D.. PART XIII: "Chest Pain" of Controversial Origin. Chapter 50. "Chest Pain" in Patients with Syndrome X. Richard O. Cannon III, M.D.. Chapter 51. "Chest Pain" in Patients with Mitral Valve Prolapse. J. Willis Hurst, M.D.. PART XIV: Final Comments. Chapter 52. The Evolution of our Knowledge and Remaining Problems. J. Willis Hurst, M.D.

Read more less

Book SynopsisEdited by Valentin Fuster, former Chairman of the American Heart Associationa s Committee on Vascular Lesions, Assessing and Modifying the Vulnerable Atherosclerotic Plaque explores the cutting--edge developments in a steadily advancing field.Table of ContentsHistorical Perspective. Contributors. Chapter 1. Evolving Concepts of Atherothrombosis (Valentin Fuster, MD, PhD and Roberto Corti, MD). Chapter 2. Cerebrovascular Diseases: Pathophysiology and Management (Debabrata Mukherjee, MD and Jay S. Yadav, MD). Chapter 3. Aortic Arch Vulnerable Plaques: Update (Pierre Amarenco, MD and Ariel Cohen, MD, PhD). Chapter 4. The Vulnerable Atherosclerotic Plaque in Peripheral Vascular Disease (Michael L. Marin, MD, Larry H. Hollier, MD, Valentin Fuster, MD, PhD, and Jeffrey Goldman, MD). Panel Discussion I. Overview of Pathology: Clinical Correlations of Atherosclerosis. Chapter 5. Thermography: A Novel Approach for Identification of Plaques at Risk of Rupture and/or Thrombosis (Mohammad Madjid, MD, Morteza Naghavi, MD, James T. Willerson, MD, and Ward Casscells, MD). Chapter 6. Intravascular Ultrasound and Plaque Vulnerability: Evidence of a Systemic Disease Process (Paul Schoenhagen, MD and Steven E. Nissen, MD, FACC). Chapter 7. Intracoronary Angioscopy to Detect Vulnerable Plaques: A Technique Whose Time Has Come? (Sergio Waxman, MD). Chapter 8. Electron Beam Computed Tomography in Assessing the Vulnerable Atherosclerotic Plaque (Robert A. O'Rourke, MD). Chapter 9. Multirow-Detector Helical Computed Tomography (Christoph R. Becker, MD, Uwe J. Schoepf, MD, and Maximilian F. Reiser, MD). Panel Discussion IIA. Overview of Imaging: Coronary Atherosclerosis. Chapter 10. Imaging of the High-Risk Plaque Using Magnetic Resonance Imaging (Zahi A. Fayad, PhD and Valentin Fuster, MD, PhD). Chapter 11. Cardiovascular Imaging with Optical Coherence Tomography (Mark E. Brezinski, MD, PhD and James Fujimoto, PhD). Panel Discussion IIB. Overview of Imaging: Atherosclerotic Regions and Imaging Modalities. Chapter 12. Plaque Instability and Remodeling: Mechanisms and Possible Misconceptions (Trine-Line Korsholm, MS, Gerard Pasterkamp, MD, PhD, MSc, and Erling Falk, MD, PhD). Chapter 13. Structural and Cellular Components of the Vulnerable Plaque: Extracellular Matrix (Renu Virmani, MD, Frank D. Kolodgie, PhD, Allen P. Burke, MD, Andrew Farb, MD, and Thomas N. Wight, PhD). Chapter 14. Structural and Cellular Components of the Vulnerable Plaque: Inflammatory Cells (Allard C. van der Wal, MD, PhD, Mischa A. Houtkamp, MSc, Onno J. de Boer, PhD, and Anton E. Becker, MD, PhD). Panel Discussion III. Structural and Cellular Components of the Vulnerable Atherosclerotic Plaque. Chapter 15. Stress and Strain: Biomechanical Guides for Imaging Plaque Stability (Hayden Huang, DSc and Richard T. Lee, MD). Chapter 16. Endothelium, Flow, and Atherothrombosis (Roberto Corti, MD, Lina Badimon, PhD, Valentin Fuster, MD, PhD, and Juan Jose Badimon, PhD). Chapter 17. Activities that Trigger Plaque Disruption (Jagmeet P. Singh, MD, DM, PhD, James Januzzi, MD, and James E. Muller, MD). Panel Discussion IV. Mechanical Forces in Plaque Disruption. Chapter 18. Matrix Metalloproteinases and Their Inhibitors (Uwe Schönbeck, PhD and Peter Libby, MD). Chapter 19. Calcium Deposition in Vulnerable Atherosclerotic Plaques: Pathophysiologic Mechanisms and Potential Implications in the Acute Coronary Syndromes (Pedro R. Moreno, MD). Panel Discussion V. Regulation of Functional Components of the Vulnerable Plaque. Index.

Read more less

Book SynopsisThe long QT syndrome has become the focus of considerable scientific attention because of the discovery of several genes responsible for its development. This book provides an account of this syndrome's history, significance. It shows why the long QT syndrome has been the focus for numerous theories of arrhythmogenesis.Table of ContentsForeword. Preface. Introduction. Historical Note. Electrophysiology Mechanisms for Arrhythmias. Clinical Presentation. Molecular Biology of LQTS. Epidemiology. Diagnosis. Therapy. Conclusion. Index.

Read more less

Book SynopsisThe second edition of this textbook builds on the success of the original version by incorporating the latest developments in the clinical evidence base for cardiac rehabilitation whilst also aligning with the wider agenda in terms of commissioning and other national guidance.Table of ContentsForeword vii List of Contributors ix Preface xiii Chapter 1 Cardiovascular Disease Prevention and Rehabilitation 1Jennifer Jones, Gill Furze, and John Buckley Chapter 2 Standards and Core Components in Cardiovascular Disease Prevention and Rehabilitation 21BACPR Standards Writing Group Chapter 3 Delivering Quality Standards 47Kathryn Carver Chapter 4 Health Behaviour Change and Education 67Linda Speck, Gill Furze, and Nick Brace Chapter 5 Lifestyle Risk Factor Management 99Jennifer Jones, John Buckley, and Gill Furze Chapter 5A Achieving Long‐term Abstinence from Tobacco Use in Patients in a Cardiovascular Prevention and Rehabilitation Setting 101Catriona Jennings and Robert West Chapter 5B Diet and Weight Management 127Alison Atrey and Rachel Vine Chapter 5C Physical Activity and Exercise 151John Buckley, Tim Grove, Sally Turner, and Samantha Breen Chapter 6 Psychosocial Health 193Linda Speck, Nick Brace, and Molly Byrne Chapter 7 Medical Risk Management 227Joe Mills, Susan Connolly, Barbara Conway, Marie-Kristelle Ross, Samantha Breen, and Dorothy J. Frizelle Chapter 8 Long‐term Management 271Sally Hinton, Ann Marie Johnson, and Gail Sheppard Chapter 9 Audit and Evaluation 285Patrick Doherty, Alex Harrison, Corinna Petre, and Nerina Onion Chapter 10 Future Prospects and International Perspectives 305Joe Mills, Sherry L. Grace, Marie‐Kristelle Ross, Caroline Chessex, Robyn Gallagher, Cate Ferry, and Vicki Wade Index 313

Read more less

Book SynopsisThis book provides an excellent introductory resource for those new to cardiac pacing and pacemakers.Table of ContentsPreface, vi Acknowledgments, vii 1 Cardiovascular anatomy and physiology, 1 2 Cardiac conduction system, 15 3 The cardiac cycle and hemodynamics, 21 4 Heart disease, 29 5 Cardiac medications related to cardiac rhythm management devices, 37 6 The basics of ecg and rhythm interpretation, 48 7 Arrhythmia analysis, 58 8 E lectricity 101, 78 9 Pacing 101, 84 10 Indications for pacing, 104 11 Pacemaker implantation, 116 12 Connecting the leads to the pulse generator, 131 13 Pacemaker modes and codes, 140 14 Single-chamber timing cycles, 153 15 Introduction to dual-chamber timing cycles, 169 16 Dual-chamber timing cycles: the atrial channel, 179 17 Dual-chamber timing cycles: the ventricular channel, 195 18 Paced ECG and EGM analysis, 205 19 Upper-rate behavior, 219 20 Advanced dual-chamber timing, 233 21 Rate-responsive pacing, 242 22 Special features, 260 23 Automatic capture algorithms, 278 24 Pacemaker follow-up, 297 25 Follow-up and troubleshooting, 310 Key answer, 316 Index, 320

Read more less

Book SynopsisMedical students encounter many challenges on their path to success, from managing their time, applying theory to practice, and passing exams. The Medical Student Survival Skills series helps medical students navigate core subjects of the curriculum, providing accessible, short reference guides for OSCE preparation and hospital placements. These guides are the perfect tool for achieving clinical success. Medical Student Survival Skills: ECG is an indispensable resource for students new to ECG interpretation and cardiac arrhythmia recognition and treatment. Integrating essential clinical knowledge with practical OSCE advice, this portable guide provides concise and user-friendly coverage of all aspects of ECG monitoring, including atrial and ventricular fibrillation, myocardial infarction, and 12 lead ECG interpretation. Easy-to-find information, plentiful illustrations, OSCE checklists and expert discussions of actual ECG trace examples help medical students andTable of ContentsPreface vii About the companion website ix 1 Introduction to ECG monitoring 1 2 Principles of ECG monitoring 3 3 Six stage approach to ECG interpretation 9 4 Sinus tachycardia 13 5 Sinus bradycardia 15 6 Sinus arrhythmia 17 7 Atrial ectopic beats 19 8 Atrial tachycardia 21 9 Atrial flutter 23 10 Atrial fibrillation 27 11 AV junctional ectopics 31 12 AV junctional escape rhythm 33 13 Junctional tachycardia 35 14 Ventricular ectopics 37 15 Idioventricular rhythm 41 16 Ventricular tachycardia 43 17 Torsades de pointes 47 18 First degree AV block 49 19 Second degree AV block Mobitz type I (Wenckebach phenomenon) 51 20 Second degree AV block Mobitz type II 53 21 Third degree (complete) AV block 55 22 Ventricular fibrillation 59 23 Ventricular standstill 61 24 Asystole 63 25 Recording a 12 lead ECG 65 26 What the standard 12 lead ECG records 71 27 Interpretation of a 12 lead ECG 75 28 ECG changes associated with myocardial infarction 81 29 ECG changes associated with myocardial ischaemia 87 30 ECG changes associated with bundle branch block 91 31 Wolff–Parkinson–White syndrome 97 Appendix A: Resuscitation council (UK) bradycardia algorithm 99 Appendix B: Resuscitation council (UK) tachycardia algorithm 101 Appendix C: Resuscitation council (UK) advanced life support (ALS) algorithm 103 Appendix D: Vagal manoeuvres 105 Appendix E: Synchronised electrical cardioversion 107 Appendix F: External (transcutaneous) pacing 111 Appendix G: Procedure for transcutaneous pacing 113 Appendix H: Definitions 115 References 117 Index 119

Read more less

Book SynopsisThe safe and trusted way to prevent and reverse heart disease Written in plain English and packed with tons of authoritative advice, Preventing & Reversing Heart Disease For Dummies includes the most up-to-date information on coronary heart disease and its treatment.Table of ContentsIntroduction 1 Part I: Getting Started with Preventing and Reversing Heart Disease 5 Chapter 1: Taking Charge of Your Heart Health 7 Chapter 2: Understanding the Onset and Outcomes of Heart Disease 15 Chapter 3: Are You at Risk of Heart Disease? How to Turn That Risk Around 39 Part II: Taking Basic Steps to Heart Health 51 Chapter 4: Forming a Partnership with Your Doctor for the Best Heart Care 53 Chapter 5: Embracing a Healthy Diet and Active Lifestyle 65 Chapter 6: Tapping the Power of the Mind/Body Connection 89 Chapter 7: Taking a Family Approach to Preventing Heart Disease 101 Part III: Tackling Key Health Risks for Heart Disease 111 Chapter 8: Combating High Blood Pressure 113 Chapter 9: Managing Bad (and Good) Cholesterol 129 Chapter 10: Managing Your Weight to Lower Your Risk 143 Chapter 11: Quitting Smoking 157 Part IV: Treating Heart Disease 169 Chapter 12: Modern Medical Arsenal: Rx Weapons for Heart Disease 171 Chapter 13: The 411 on Invasive and Surgical Procedures 189 Chapter 14: Exploring Complementary Therapies 201 Chapter 15: Taking Back Your Life after a Heart Event 213 Part V: Heart-Healthy Recipes 225 Chapter 16: Heart-Healthy Breakfasts 227 Chapter 17: Heart-Healthy Lunches 243 Chapter 18: Heart-Healthy Dinners 263 Chapter 19: Snacks, Starters, and Desserts 287 Part VI: The Part of Tens 299 Chapter 20: Ten Differences in Heart Disease between Women and Men 301 Chapter 21: Ten Cardiac Symptoms You Shouldn’t Ignore 307 Chapter 22: Ten Heart Tests to Consider or Avoid 311 Chapter 23: Ten Tips for Involving Your Family in a Heart-Healthy Lifestyle 317 Appendix: Metric Conversion Guide 323 Index 325

Read more less

Book SynopsisTable of ContentsPreface, vi About the companion website, vii 1 Anatomy and Basic Physiology, 1 2 ECG Recording and ECG Leads, 21 3 The Normal ECG and the Frontal Plane QRS Axis, 53 4 The Components of the ECG Waves and Intervals, 73 5 P waves and Atrial Abnormalities, 85 6 Chamber Enlargement and Hypertrophy, 99 7 Intraventricular Conduction Defects, 105 8 Coronary Artery Disease and Acute Coronary Syndromes, 123 9 Acute Pericarditis, 187 10 The ECG in Extracardiac Disease, 193 11 Sinus Node Dysfunction, 203 12 Premature Ventricular Complexes (PVC), 217 13 Atrioventricular Block, 227 14 Atrial Rhythm Disorders, 243 15 Ventricular Tachycardias, 279 16 Ventricular Fibrillation and Ventricular Flutter, 305 17 Preexcitation and Wolff -Parkinson-White Syndrome (WPW), 311 18 Electrolyte Abnormalities, 327 19 Electrophysiologic Concepts, 333 20 Antiarrhythmic Drugs, 351 21 Pacemakers and their ECGs, 359 22 Errors in Electrocardiography Monitoring, Computerized ECG, Other Sites of ECG Recording, 391 23 How to Read an ECG, 407 Index, 425

Read more less

Book SynopsisRapid Cardiac Care is an indispensable resource for all frontline staff working with acutely ill patients. Offering easy access to the knowledge base needed to provide rapid, safe and effective cardiac care, it is ideal for newly qualified healthcare professionals including, nurses, paramedics, cardiac technicians, junior medics, and physiotherapists. Key features include: Essential information to support the assessment of the cardiac patient including focused history taking and physical assessment, rhythm interpretation and 12-lead ECG assessmentPractical guidance on how to care for patients with cardiac emergencies, including acute coronary syndromes, arrhythmias, heart failure and cardiac arrestA quick reference A-Z section that explores a wide range of conditions affecting the heart, each with a comprehensive overview of patient presentation and strategies to guide patient assessment and managementDiagrams and images are provided to facilitate learningTable of ContentsList of Abbreviations ix Preface xii Acknowledgements xiii Part 1: Cardiac Anatomy and PhysiologyAnatomy 3 Cardiac cycle 5 Cardiac conduction system 6 Coronary circulation 8 Part 2: Rapid Cardiac AssessmentIntroduction 13 Cardiac history taking 14 Physical examination 18 Cardiac Monitoring 21 Rapid rhythm recognition 23 Cardiac investigations 25 Part 3: Rapid 12‐lead ECG InterpretationIntroduction 31 Cardiac vectors and axis 33 Rapid ECG analysis tool 34 Rate and rhythm assessment 35 QRS axis calculation 36 Pre‐excitation syndromes 37 Bundle branch block and fascicular block 38 Myocardial ischaemia or infarction 41 Other abnormalities seen on the 12‐lead ECG 44 Part 4: Cardiac Conditions A–ZAcute coronary syndromes 47 Acute coronary syndromes: treatment and interventions 51 Acute heart failure 54 Aortic aneurysm 57 Aortic dissection 59 Aortic regurgitation 61 Aortic stenosis 63 Arrhythmogenic right ventricular cardiomyopathy 65 Atrial fibrillation 67 Atrial flutter 69 Brugada syndrome 71 Cardiac arrest 73 Cardiac arrhythmias: treatment and interventions 75 Cardiogenic shock 79 Dilated cardiomyopathy 81 Heart blocks 83 Hypertension 86 Hypertrophic cardiomyopathy 88 Infective endocarditis 90 Long QT syndrome 92 Marfan syndrome 94 Mitral regurgitation 96 Mitral stenosis 98 Myocarditis 100 Pericarditis 102 Supraventricular tachycardia 104 Takotsubo cardiomyopathy 107 Ventricular tachycardia 109 Wolff‐Parkinson‐White syndrome (Pre‐excitation syndrome) 111 Index 113

Read more less

Book SynopsisCardiac Problems in Pregnancy offers clinicians the most detailed and comprehensive guide to diagnosing and managing pregnancy-associated cardiovascular diseases currently available. Covering a wide spectrum of congenital and acquired cardiovascular conditions, its extensive contents examine diseases of the heart with an expert awareness of the implications of pregnancy and the attendant physiological changes it brings. Such guidance is vitally required in an age in which congenital and acquired heart diseases are the leading causes of non-obstetrical maternal morbidity and mortality. Featuring 36 new or extensively revised chapters, this fourth edition of the book complements coverage of the latest research and clinical advances with a complete and up-to-date bibliography of literature on pregnancy in women with cardiovascular conditions. It also serves as a practical, step-by-step companion for those caring for heart disease patients during pregnancy, labor, and theTable of ContentsAbout the Editor ix List of Contributors x Preface xiii Acknowledgments xiv Part I Physiologic Changes During Normal Pregnancy and the Puerperium 11 Hemodynamic and Cardiac Function 3Ofer Havakuk and Uri Elkayam Part II Cardiac Evaluation of the Pregnant Woman 17 2 Cardiovascular Evaluation During Pregnancy 19Uri Elkayam 3 Cardiovascular Imaging in the Pregnant Patient 32Patrick Colletti and Uri Elkayam Part III Cardiac Disorders and Pregnancy 41 4 Risk Assessment Prior and During Pregnancy 43Samuel C. Siu and Candice K. Silversides 5 Congenital Heart Disease and Pregnancy 60Candice K. Silversides, Jack M. Colman, and Samuel C. Siu 6 Native Valvular Heart Disease and Pregnancy 75Uri Elkayam 7 Pregnancy in the Patient with Prosthetic Heart Valves 90Uri Elkayam 8 Myocarditis and Pregnancy 107Avraham Shotan and Andrei Keren 9 Pericardial Disorders and Pregnancy 116Marla A. Mendelson 10 Peripartum Cardiomyopathy 128Sorel Goland and Uri Elkayam 11 Dilated Cardiomyopathy and Pregnancy 155Kathleen Stergiopoulos and Fabio V. Lima 12 Hypertrophic Cardiomyopathy and Pregnancy 167Iris M. van Hagen, Uri Elkayam, Sorel Goland, and Jolien W. Roos-Hesselink 13 Left Ventricular Noncompaction 181Radha J. Sarma 14 Acute Myocardial Infarction and Pregnancy 201Uri Elkayam and Ofer Havakuk 15 Cardiac Arrhythmias and Pregnancy 220Danna Spears and Uri Elkayam 16 Pulmonary Arterial Hypertension and Pregnancy 252Dianne Zwicke, Sara Paulus, and Vinay Thohan 17 Infective Endocarditis 261Ramin Ebrahimi, Michael Shenoda, Sheila Sahni, and David Fisk Part IV Vascular Disease in Pregnancy 275 18 Vascular Dissections and Aneurysms During Pregnancy 277Afshan B. Hameed 19 Marfan Syndrome and Pregnancy 285Sorel Goland and Uri Elkayam 20 Non-Marfan Aortopathies and the Pregnant Patient 305John Bois and Heidi Connolly 21 Takayasu’s Arteritis and Pregnancy 319Abha Khandelwal 22 Thromboembolic Disease in Pregnancy 326Courtney C. Bilodeau and Karen Rosene-Montella 23 Amniotic Fluid Embolism and Pregnancy 334Irene A. Stafford, Steven L. Clark, and Gary A. Dildy 24 Hypertension During Pregnancy 339Chonyang L. Albert and Leslie Cho 25 Syncope in Pregnancy 349Paul S. Gibson Part V Cardiac Surgery and Catheter Based Interventions During Pregnancy 359 26 Cardiac Surgery During Pregnancy 361Anita Nguyen and Hartzell V. Schaff 27 Catheter-Based Interventions in Women with Heart Disease During Pregnancy 370Anil Mehra, Gassan Muadi, Pavan Reddy, and Uri Elkayam 28 Analgesia and Anesthesia During Pregnancy, Labor, and Delivery 389Katherine W. Arendt 29 Cardiopulmonary Resuscitation of Pregnant Women 397Joan Briller 30 Pregnancy After Cardiac Transplantation 419Serban Constantinescu, Dawn P. Armenti, Lisa A. Coscia, Lynn R. Punnoose, John M. Davison, and Michael J. Moritz Part VI Cardiovascular Drug Therapy During Pregnancy 433 31 Pharmacokinetics of Drugs in Pregnancy and Lactation 435Irving Steinberg 32 Cardiovascular Drugs in Pregnancy and Lactation 456Petronella G. Pieper, Uri Elkayam, Joy Eskandar, and Titia P.E. Ruys 33 Tocolytic Therapy in the Cardiac Patient 491Joseph G. Ouzounian 34 Fertility Control in the Cardiac Patient 497Joan Briller, Mark R. Johnson, and Jolien W. Roos-Hesselink Part VII Labor and Delivery 513 35 Management of Labor and Delivery in a Cardiac Patient 515Rohan D’Souza and Mathew Sermer 36 Cardiac Effects of Drugs Used for Induction of Labor and Prevention and Treatment of Postpartum Hemorrhage 530Mark R. Johnson Index 537

Read more less

Book SynopsisA fresh assessment of ischemic electrocardiography, its prognostic correlations, and the concepts and principles that underlie its use The electrocardiogram (ECG) is integral to the accurate diagnosis and optimal management of patients with ischemic heart disease. Picking up a wide range of indicators, it provides valuable prognostic data to cardiologists and emergency medicine specialists for whom ECG readings are a trusted and everyday resource. Electrocardiography in Ischemic Heart Disease is designed to help enhance such clinicians'' understanding of ECG recordings and their relationship to anatomical patterns of myocardial ischemia, thereby facilitating the continued improvement of patient care. For this new edition, the book''s globally recognized team of authors has revised and expanded the original text to bring it up to date with the cardiology of today. Practical explanations of electrophysiological mechanisms, ischemic insults, and arterial occlusions Table of ContentsForeword to the Second Edition vii Foreword to the First Edition ix Introduction xi Part I The ECG Changes Secondary to Ischemic Heart Disease: Electrophysiologic Bases 1 1 Anatomy of the Heart: The Importance of Imaging Techniques Correlations 3 2 Electrophysiological Bases of Ischemic Heart Disease 27 3 T Wave Changes 41 4 ST‐segment Changes 69 5 QRS and Other Waves Changes 81 Part II The ECG in Different Clinical Settings of Ischemic Heart Disease: Correlations and Prognostic Implications 95 6 The Role of the ECG in Patients with Acute Chest Pain 97 7 Acute Coronary Syndrome with ST Elevation (STE‐ACS) 111 8 ST‐Segment Elevation: Differentiating ST‐Elevation Myocardial Infarction from Non‐Ischemic ST Elevation 181 9 Acute Coronary Syndrome without ST‐Segment Elevation 207 10 Common Mistakes in the Diagnosis of Acute Coronary Syndromes 231 11 ECG in Complications of Acute Coronary Syndromes 249 12 Myocardial Infarction with and without Q Wave or Equivalent 277 13 Silent Ischemia 345 14 The ECG as a Predictor of Ischemic Heart Disease 353 15 Telemedicine in the Diagnosis of Ischemic Heart Disease Through the Surface Electrocardiogram 355 References 369 Index 401 Color plate section can be found facing page 180

Read more less

Book Synopsisb>Clinical Electrocardiography Electrocardiography is a transthoracic recording over a period of time. Electrical activity is detected and recorded via electrodes attached to the outer surface of the skin. The recording produced by this noninvasive procedure is termed as electrocardiogram. ECGs are used to measure the rate and regularity of heartbeats as well as the size and position of the chambers, the presence of any damage to the heart, and the effects of drugs or devices used to regulate the heart. Clinical Electrocardiography is the clearest and most accessible guide available to the application and interpretation of the ECG in clinical practice. The book proceeds from the belief that ECG patterns should not be memorized, but rather must be understood based on how they originate; it is only by achieving this level of understanding that clinicians can make the most informed diagnoses and thus manage patient care with complete confidence. This fully revised 5Table of ContentsPreface by Prof. Antoni Bayés de Luna vii Preface by Drs Miquel Fiol‐Sala, Antoni Bayes‐Genís, and Adrián Baranchuk viii Foreword by Dr Marcelo V. Elizari ix Foreword by Dr Pedro Brugada xi Recommended Reading xiii Part 1 Introductory Aspects 1 The Electrical Activity of the Heart 3 2 The History of Electrocardiography 11 3 Utility and Limitations of the Surface ECG: Present and Future 17 Part 2 The Normal ECG 4 The Anatomical Basis of the ECG: From Macroscopic Anatomy to Ultrastructural Characteristics 25 5 The Electrophysiological Basis of the ECG: From Cell Electrophysiology to the Human ECG 35 6 The ECG Recording: Leads, Devices, and Techniques 56 7 Characteristics of the Normal Electrocardiogram: Normal ECG Waves and Intervals 69 8 Diagnostic Criteria: Sensitivity, Specificity, and Predictive Value 100 Part 3 Abnormal ECG Patterns 9 Atrial Abnormalities 107 10 Ventricular Enlargement 133 11 Ventricular Blocks 170 12 Ventricular Pre‐excitation 215 13 Ischemia and Necrosis 229 Part 4 Arrhythmias 14 Mechanisms, Classification, and Clinical Aspects of Arrhythmias 299 15 Active Supraventricular Arrhythmias 321 16 Active Ventricular Arrhythmias 350 17 Passive Arrhythmias 376 18 Diagnosis of Arrhythmias in Clinical Practice: A Step‐by‐Step Approach 396 Part 5 The Clinical Usefulness of Electrocardiography 19 The Diagnostic Value of Electrocardiographic Abnormalities 411 20 The ECG in Different Clinical Set of Ischemic Heart Disease 427 21 Inherited Heart Diseases 478 22 The ECG in Other Heart Diseases 498 23 The ECG in Other Diseases and Different Situations 520 24 Other ECG Patterns of Risk 539 25 Limitations of the Conventional ECG: Utility of Other Techniques 552 26 The Electrocardiology of the Twenty‐First Century 571 Index 574

Read more less

Book SynopsisTable of ContentsAuthor biography, xi Preface – Direction to “Perfect 24-hour Blood Pressure Control”, xv Acknowledgments, xix 1 Evidence and scientific rationale for ambulatory blood pressure monitoring (ABPM), 1 Diurnal BP variation and the concept of “perfect 24-hour BP control”, 1 Nocturnal hypertension and nocturnal BP dipping status, 3 Nocturnal BP dipping status, 3 Non-dipper patterns of BP and pulse rate, 3 Riser pattern of BP and cardiovascular disease risk, 4 Riser pattern and HF, 7 Riser pattern and brain damage, 15 Nocturnal hypertension, 17 Associated Conditions and Mechanisms of Nocturnal Hypertension, 20 Mechanism of cardiovascular risk of nocturnal hypertension, 22 Extreme dipping, 24 Morning surge in BP, 27 Definition of MBPS, 33 Morning BP surge and cardiovascular disease, 34 Morning BP surge and organ damage, 37 Determinants of MBPS, 43 Mechanism of morning risk, 44 Morning BP surge and hemostatic abnormalities, 46 Vascular mechanism of exaggerated morning BP surge, 49 BP Variability and systemic hemodynamic atherothrombotic syndrome (SHATS), 52 The resonance hypothesis of BP surge, 53 Orthostatic hypertension, 54 Ambulatory BP variability, 57 Visit-to-visit variability in office BP, 58 Vicious cycle between BP variability and vascular disease—SHATS, 59 White-coat and masked hypertension, 71 White-coat hypertension, 73 Masked hypertension, 75 Advances in ABPM, 75 Development of information and communication technology-based multi-sensor (IMS)-ABPM, 75 New ABPM indices, 77 HI-JAMP registry, 82 2 Scientific rationale for HBPM, 85 Five prospective, general practitioner-based, home BP studies, 85 Morning hypertension, 85 Control status of morning home BP in the J-HOP study, 88 Evidence for morning hypertension control, 89 Home BP variability, 99 Morning–evening difference (ME-dif), 99 SD, CV, ARV, and VIM of home BP, 101 Maximum home SBP, 103 Orthostatic Home BP Change, 103 Seasonal variation of home BP and “thermosensitive hypertension”, 109 Alcohol, 113 Daytime hypertension (stress hypertension), 115 Nighttime HBPM, 115 Cutting-edge of HBPM, 115 Basic nighttime home BP monitoring (Medinote), 119 Clinical evidence using nocturnal HBPM: J-HOP nocturnal BP study, 119 Trigger nighttime BP monitoring, 127 IT-based trigger nighttime BP monitoring system and the SPREAD study, 133 CPAP adherence and nighttime BP surge, 135 Antihypertensive medication on nighttime BP surge, 139 Wrist home HBPM and WISDOM Night study, 145 3 Practical use of ABPM and HBPM, 147 Concept and positioning of ABPM and HBPM in guidelines, 147 Recent guidelines, 147 Diagnosis of masked and white-coat hypertension, 147 Definition of morning hypertension, 148 Definition of nocturnal hypertension, 150 When to use HBPM and ABPM, 150 Clinically suspected SHATS, 152 Cardio-ankle vascular index (CAVI), 154 Coupling study, 154 How to measure home BP, 155 Nighttime home BP measurement schedule, 159 ABPM parameters, 162 24-hour BP, 166 Daytime BP and nighttime BP, 166 Morning BP parameters, 166 Nighttime BP parameters, 166 MBPS parameters, 166 Nighttime BP surge parameters, 166 Nighttime BP dipping parameters, 167 ABPM-defined hypertension subtypes, 167 Home and ambulatory BP-guided management of hypertension, 167 STEpwise-Personalized 24-hour BP control approach (STEP24 approach), 167 Targeting morning hypertension (Step 1), 167 Targeting nocturnal hypertension (Step 2), 171 Pressor mechanism-based nighttime BP management strategy, 173 4 BP targets, when to initiate antihypertensive therapy, and nonpharmacological treatment, 177 Clinical implications of antihypertensive treatment, 177 SPRINT and automated office BP, 177 Meta-analysis of antihypertensive trials, 177 When to initiate antihypertensive therapy, 178 Patient preference, 178 Sodium intake, 179 Other dietary requirements, 181 Exercise, 183 Sleep hygiene, 185 Housing condition, 185 Applications and algorithms to facilitate lifestyle modification: CureAPP, 187 5 Antihypertensive medication, 189 Concept of 24-hour BP lowering including nighttime and morning BPs, 189 Chronotherapy, 189 Antihypertensive drug choice, 190 Calcium channel blockers, 190 Amlodipine, 194 Nifedipine, 195 Cilnidipine, 197 Azelnidipine, 199 Angiotensin-converting enzyme inhibitors, 201 Angiotensin receptor blockers (ARBs), 201 Valsartan, 201 Telmisartan, 204 Candesartan, 204 Olmesartan, 205 Azilsartan, 206 Diuretics, 212 Alpha-adrenergic blockers and beta-adrenergic blockers, 214 Mineralocorticoid receptor blockers (MRB), 215 Angiotensin receptor-neprilysin inhibitor (ARNi), 217 Endothelin receptor antagonists (ERA), 221 Combination therapy, including single pill combinations, 222 First-line therapy, 222 Second-line therapy, 222 Clinical trials of antihypertensive combination therapy, 226 Management of resistant hypertension, 238 Third-line therapy, 238 Fourth-line therapy, 239 SGLT2 inhibitors, 240 SACRA study, 243 SHIFT-J study, 244 LUSCAR study, 248 Summary, 250 Other BP-lowering therapies, 252 Hypnotics, 252 XOR inhibitor, 252 Herbal medication, 253 6 Renal denervation, 255 Unsolved issues in the treatment of hypertension and the era for renal denervation, 255 Hypothesis of perfect 24-hour BP control by renal denervation, 256 History, 257 Advances in devices, 262 Symplicity spyral system (radiofrequency thermal ablation), 262 Iberis® system, 264 Paradise system (ultrasonic thermal ablation), 264 Peregrine system (trans-arterial alcohol injection), 265 Other energy modalities, 266 Evidence for renal denervation treatment of hypertension from Sham-controlled trials, 266 SPYRAL trials, 266 Radiance-Htn Solo study, 268 Evidence from Japanese populations, 269 The Global Symplicity Registry (GSR), 269 Safety of the renal denervation procedure, 270 24-hour BP lowering profile for cardiovascular protection, 270 Responders and clinical indications, 272 7 Blood pressure linked telemedicine and telecare, 278 Anticipation medicine, 278 Innovation technology, 280 Concept of “trigger” management, 282 Multisensors and the real-time hybrid Wi-SUN/Wi-Fi transmission system, 283 AI and anticipation models, 284 Development of wearable beat-by-beat (surge) BP monitoring, 285 Surge index, 292 Disaster cardiovascular prevention (DCAP) network, 294 Successful anticipation model of ICT-based BP control, 302 Disaster hypertension, 302 COVID-19 era, 305 8 Asia perspectives, 311 What is the HOPE Asia Network?, 311 HOPE Asia Network achievements, 312 Characteristics of cardiovascular disease in Asia, 315 Obesity and salt intake in Asia, 315 24-hour ambulatory BP profile in Asia, 320 Asia BP@Home Study, 325 References, 328 Index, 368

Read more less

Book SynopsisTable of ContentsList of contributors Preface About the companion website Part I Structural Interventions for the Aortic Valve 1. Natural History and Hemodynamic assessment of aortic valvular disease 2. Pathology Insights of Aortic Valve Disease 3. The Top Ten Clinical Trials in Patients Undergoing Transcatheter Aortic Valve Implantation: The Evolution of a Transformative Therapy into Clinical Practice 4. Present and Future Generation Transcatheter Valves 5. Computed Tomography for Transcatheter Aortic Valve Replacement Planning – Current Perspectives and Future Directions 6. Optimal Selection of TAVR Devices 7. Transfemoral TAVR step by step (Balloon Expandable and Self Expandable Valves) 8. Balloon Aortic Valvuloplasty: Current Clinical Role and Technical Aspects 9. Challenging anatomy scenarios in TAVR 10. TAVR for the Bicuspid Aortic Valve 11. TAVR for Pure Native Valve Aortic Regurgitation 12. Aortic Valve in Valve Interventions 13. Prevention and Management of Coronary Occlusion in TAVR 14. Coronary artery disease and TAVR: Timing and patient selection for coronary intervention in patients that are planned for TAVR 15. Conduction Disturbances Associated with TAVR: Clinical impact and Techniques to Minimize 16. Management of conduction disturbances post Transcatheter Aortic Valve Replacement(TAVR) 17. TAVR mechanical complications prevention and management 18. Pathological insights of TAVR degeneration and thrombosis 19. Clinical Implications of Valve Thrombosis and early thickening: (Management of Antiplatelets and Anticoagulation post TAVR) 20. Transcatheter Aortic Valve Replacement and Stroke 21. Current Evidence Of Neuroprotection In TAVR 22. Difficult Transfemoral Access for TAVR and Bailout Techniques 23. Alternative Access for TAVR 24. Vascular Access, Complications and Closure Options for TAVR PART II Structural Interventions for the Mitral Valve 25. Natural History of Mitral Valve Disease 26. Hemodynamic Assessment of the Mitral Valve 27. Echocardiographic Assessment Prior to Mitral Valve Edge to Edge Repair 28. Intra procedural TEE for Mitral Valve Structural Interventions 29. Surgical Trials for Mitral Valvular Diseases 30. Surgical Techniques for Mitral Valve Repair 31. Structural Interventions for Mitral Stenosis 32. Transcatheter Edge To Edge Repair Trials : The EVEREST and COAPT Trials 33. TEER - The MitraClip Procedure 34. Transcatheter Edge to Edge Repair Challenging Anatomy & MitraClip Tips and Tricks 35. MitraClip complications : Prevention and Management 36. CT Imaging for TMVR 37. Transcatheter Mitral Valve in Valve ; Valve in MAC and Valve in Ring 38. Transcatheter Mitral Valve in Valve : Technical Considerations and Step by Step 39. Transeptal systems for TMVR and Transcatheter Devices for Mitral Annuloplasty 40. Tethered Self Expanding TMVR Systems (Tendyne) 41. Self Expanding TMVR systems. Intrepid Valve PART III Structural Interventions for the Tricuspid Valve 42. Natural History and hemodynamic assessment of Tricuspid Valve Diseases 43. Indications and Outcomes for Surgical Tricuspid Valve Repair 44. Intraprocedural Imaging for Tricuspid Valve Interventions 45. Transcatheter Tricuspid Valve Devices Landscape 46. Progress in Transcatheter Tricuspid Valve Replacement 47. Tricuspid Valve in Valve and Valve in Ring 48. Heterotopic Caval valve implantation (CAVI) PART IV Structural Interventions for Management of Perivalvular Leaks 49. Aortic PVL Closure: Techniques and Devices for Surgical and Transcatheter Prosthesis 50. Mitral Perivalvular Leak Closure: Imaging and Interventional Approaches PART V Left Atrial Appendage Closure 51. Current indications of LAA closure 52. Imaging for LAA interventions 53. Devices for Left Atrial Appendage Closure 54. LAA Technique and Challenging Scenarios 55. Preventing and Managing Complications of LAA Closure 56. Natural History of Hypertrophic Cardiomyopathy 57. Alcohol Septal Ablation in HCM 58. Transcatheter Edge to Edge Repair for Hypertrophic Cardiomyopathy 59. Interatrial Shunt Creation PART VII Selected Adult Congenital Structural Interventions 60. Shunts Hemodynamics and Calculations 61. PFO Closure 62. ASD Closure 63. VSD Closure 64. Percutaneous Treatment of Aortic Coarctation 65. Pulmonic Valve Interventions PART VIII Miscellaneous 66. Hemodynamic Pearls in Adult Structural Heart Disease 67. Closure of Coronary Artery Fistulas 68. Renal Denervation 69. Acute Pulmonary Embolism Interventions: Data and Indications 70. Acute pulmonary embolism intervention: Devices and Techniques 71. ECMO for Structural Interventions 72. Best Practices for Mechanical Circulatory Support with Impella for Acute Myocardial Infarction Cardiogenic Shock and Selected Structural Interventions 73. Transcatheter Interventions for Aortic Valve Insufficiency in Patients with Left Ventricular Assist Device (LVAD) Index

Read more less

Book SynopsisThis book explains all of the stages involved in developing medical devices; from concept to medical approval including system engineering, bioinstrumentation design, signal processing, electronics, software and ICT with Cloud and e-Health development. Medical Instrument Design and Development offers a comprehensive theoretical background with extensive use of diagrams, graphics and tables (around 400 throughout the book). The book explains how the theory is translated into industrial medical products using a market-sold Electrocardiograph disclosed in its design by the Gamma Cardio Soft manufacturer. The sequence of the chapters reflects the product development lifecycle. Each chapter is focused on a specific University course and is divided into two sections: theory and implementation. The theory sections explain the main concepts and principles which remain valid across technological evolutions of medical instrumentation. The Implementation sections show how the theoryTable of ContentsForeword xv Preface xvii Acknowledgment xxi 1 System Engineering 1 Chapter Organization 1 Part I: Theory 4 1.1 Introduction 4 1.2 Problem Formulation in Product Design 4 1.3 The Business Context for Design 6 1.4 The Engineering Product Design Process 10 1.5 System-subsystem Decomposition 15 1.6 The Product Development Life Cycle 21 1.7 Project Management in Product Design 24 1.8 Intellectual Property Rights and Reuse 30 Part II: Implementation 32 1.11 The ECG: Introduction 32 1.11.1 The ECG’s diagnostic relevance 32 1.11.2 ECG Types 33 1.12 The ECG Design Problem Formulation 34 1.13 The ECG Business Plan 36 1.13.1 Market Size and Trend 37 1.13.2 Core and Distinctive Features 38 1.14 The ECG Design Process 40 1.14.1 Transverse Activities of the ECG Design Process 43 1.14.2 Core Activities of the ECG Design Process 44 1.15 ECG System–subsystem Decomposition 44 1.15.1 Hardware Platform Decomposition 45 1.15.2 Software Application Decomposition 45 1.16 ECG Product Life Cycle 46 1.16.1 Overcoming Risk of Inadequate Visualization of ECG Signal 47 1.16.2 Overcoming Risk of Error Fixing in System Integration 50 1.16.3 Overcoming Risks for Non-stable/Unfeasible Requirements 50 1.17 The ECG Development Plan and Project Management 51 1.18 IPR and Reuse Strategy for the ECG 55 References 57 2 Concepts and Requirements 59 Chapter Organization 59 Part I: Theory 61 2.1 Introduction 61 2.2 The Medical Instrumentation Approach 62 2.3 Extraction of Physiological Parameters 67 2.4 Pressure and Flow 70 2.4.1 Blood Pressure 72 2.4.2 Blood Flow and Hemodynamics 74 2.5 Biopotential Recording 79 2.6 Electroencephalography 81 2.7 Electromyography 85 Part II: Implementation 88 2.8 Introduction 88 2.9 Requirements Management 89 2.10 Medical Instruments Requirements and Standards 91 2.11 ECG Requirements 94 2.12 The Patient Component 96 2.12.1 The Heart’s Pumping Function and the Circulatory System 96 2.12.2 Heart Conduction ‘Control’ System 97 2.13 The ECG Method for Observation 99 2.13.1 Recording the Heart’s Electrical Signals 99 2.13.2 ECG Definition and History 103 2.13.3 ECG Standard Method of Observation 103 2.14 Features of the Observations 108 2.14.1 ECG Signal 108 2.14.2 Clinically Significant Signal 110 2.14.3 Power Line Noise 117 2.14.4 Isoelectric Line Instability 118 2.14.5 Muscle Artifacts 119 2.15 Requirements Related to Measurements 119 2.16 Safety Requirements 126 2.16.1 EMC Performance 128 2.17 Usability and Marketing Requirements 131 2.18 Environment Issues 132 2.19 Economic Requirements 134 References 135 3 Biomedical Engineering Design 137 Chapter Organization 138 Part I: Theory 139 3.1 Design Principles and Regulations 139 3.2 General Design System Model 141 3.3 Pressure and Flow Instruments 142 3.3.1 Blood Pressure Instruments 144 3.3.2 Flow Measurements 146 3.3.3 Measuring Oxygen Concentration 147 3.4 Biopotential Instruments 148 3.4.1 Electroencephalographs 148 3.4.2 Electromyographs 151 3.5 The Design Process 152 3.5.1 The Conceptual Design 155 3.5.2 System-wide Design Decisions 156 3.5.3 System Architectural Design 157 3.5.4 Risk Management 157 Part II: Implementation 160 3.6 ECG-wide Decisions 160 3.6.1 The Gamma Cardio CG Use Case 160 3.6.2 Human Factors and the User Interface Design 161 3.6.3 Patient Interface: the Biopotential Electrodes 167 3.7 The ECG System Architectural Design 170 3.7.1 Subsystem Identification 170 3.7.2 The Communication Interfaces 171 3.7.3 Acquisition Hardware Requirements 174 3.7.4 Firmware Requirements 176 3.7.5 Software Application Requirements 177 3.7.6 Concept of Execution among Subsystems 178 3.8 Gamma Cardio CG Technical File Structure 179 References 180 4 Signal Processing and Estimation 181 Chapter Organization 181 Part I: Theory 184 4.1 Discrete Representations of Analog Systems 184 4.2 Discrete Fourier Transform 189 4.2.1 Discrete Fourier Transform Statistics 194 4.3 Estimation Theory Framework 197 4.3.1 Minimum Mean Square Error Estimate 199 4.3.2 Minimum Mean Absolute Error Estimate (MMAE) 201 4.3.3 Maximum A Posteriori (MAP) Probability Estimate 202 4.3.4 Maximum Likelihood Estimation (MLE) 203 4.4 Performance Indicators 204 4.4.1 Efficient Estimators 208 4.4.2 Fisher’s Information Matrix 209 4.4.3 Akaike Information Criterion 212 Part II: Implementation 214 4.5 Analog to Digital Conversion 214 4.5.1 Indirect Sampling versus Direct Sampling 214 4.5.2 Quantizer Design 216 4.6 Signal Denoising 221 4.6.1 White Gaussian Signals in Additive White Gaussian Noise 221 4.6.2 Denoising of Gaussian Cyclostationary Signals 222 4.6.3 MMSE Digital Filter 222 4.7 Time of Arrival Estimation 224 References 229 5 Applied Electronics 231 Chapter Organization 231 Part I: Theory 233 5.0 Architectural Design 235 5.1 Sensors 236 5.2 Circuit Protection Function 243 5.2.1 Johnson Noise 246 5.2.2 Transient Voltage Suppressors 247 5.2.3 RF Filter Circuit Protection 248 5.2.4 Circuit Frequency Response 251 5.3 Buffer Stage 254 5.3.1 Operational Amplifiers 256 5.4 Analog Signal Processing 258 5.4.1 Summing Amplifier Circuit 259 5.4.2 Analog Signal Switching 260 5.5 Interference and Instrumentation Amplifiers 262 5.5.1 Eliminating In-band Interference 262 5.5.2 Patient Model 267 5.5.3 The ECG Model 268 5.5.4 Right Leg Connection 270 5.5.5 Right Leg Driver Circuit 272 5.6 Analog Filtering 273 5.6.1 Frequency Domain 273 5.6.2 Analog versus Digital Filtering 278 5.7 ADC Conversion 279 5.8 Programable Devices 285 5.9 Power Module 289 5.9.1 Power Sources 290 5.9.2 Electrical Safety and Appliance Design 294 5.9.3 Power Module Design 298 5.10 Baseband Digital Communication 301 5.10.1 Data Transmission Elements 302 Part II: Implementation 313 5.20 Gamma Cardio CG Architecture 313 5.20.1 ECG Design Choices 314 5.20.2 Gamma Cardio CG Complete Scheme 317 5.21 ECG Sensors 317 5.22 Gamma Cardio CG Protection 321 5.23 Gamma Cardio CG Buffer Stage 325 5.24 The Lead Selector 327 5.24.1 Calibration 331 5.25 ECG Amplification 332 5.25.1 ECG Circuits 333 5.25.2 Input Dynamic Range: Requirement Demonstrations 337 5.25.3 Gain Error: Requirement Demonstrations 338 5.26 Analog Filtering 339 5.27 The ADC Circuit 342 5.28 Programable Devices 346 5.28.1 Circuit Design 347 5.28.2 The Clock 348 5.29 Power Module 351 5.29.1 Power Module Circuit 353 5.30 Communication Module 353 Conclusion 357 References 358 6 Medical Software 359 Chapter Organization 359 Part I: Theory 361 6.1 Introduction 361 6.1.1 Intrinsic Risks and Software Engineering 362 6.1.2 Main Concepts in Software Development 363 6.1.3 Regulatory Requirements for Software 364 6.2 The Process: a Standard for Medical Software 365 6.2.1 IEC/EN 62304 Overview 365 6.2.2 Risk Analysis for Hardware and Software Design 368 6.2.3 Software Safety Classification 370 6.2.4 System Decomposition and Risks 371 6.2.5 Impact of Safety Classification 372 6.2.6 Soup 372 6.3 Risk Management Process 374 6.3.1 Risk Management in Software 376 6.3.2 Risk Management for Medical Instrument Software 377 6.4 Software Development Process 379 6.4.1 Software Development Planning 380 6.4.2 Software Requirements Analysis 381 6.4.3 Software Architectural Design 382 6.4.4 Detailed Software Design 385 6.4.5 Software Unit Implementation and Verification 385 6.4.6 Software Integration and Integration Testing 387 6.4.7 Software System Testing 388 6.4.8 Software Release 388 6.5 Software Configuration Management Process 389 6.6 Software Problem Resolution Process 391 6.7 Software Maintenance Process 392 6.8 Guidelines on Software Design 393 6.8.1 Definitions 395 6.8.2 Basic Recommendations 396 6.8.3 Software Core Services 396 6.8.4 Defensive Programing 398 Part II: Implementation 400 6.9 System Decomposition 400 6.9.1 Gamma Cardio CG Use Case 400 6.9.2 System Decomposition 401 6.10 Risk Management 402 6.11 Software Application 403 6.11.1 Software Requirements 403 6.11.2 Architectural Design 407 6.11.3 Elaboration Module 409 6.12 Firmware 411 6.12.1 Firmware Requirements 411 6.12.2 Architectural Design 413 6.12.3 Automatic Test Capability 416 References 418 7 C-health 419 Chapter Organization 420 Part I: Theory 421 7.1 Introduction 421 7.1.1 The Assessment Framework 421 7.1.2 Assessment Framework for the Health Sector 422 7.2 The Cloud Computing Model 426 7.2.1 Basics of Cloud Computing 426 7.2.2 Cloud Platforms 428 7.2.3 Services in the Cloud 430 7.2.4 The Cloud Shape 432 7.2.5 Features of the Clouds 434 7.3 e-Health 435 7.3.1 Interoperability in e-Health 437 7.4 Electronic Health Record (EHR) 442 7.5 c-Health 445 Part II: Implementation 449 7.6 Telecardiology 450 7.6.1 Application Scenario 450 7.7 Telecardiology Technology 451 7.8 Workflow in Telecardiology 455 7.8.1 Basic Workflows 455 7.8.2 Alternative Workflows 457 7.8.3 Where and When Telecardiology Can Be Used 460 7.9 Risks of Telecardiology 463 References 465 8 Certification Process 467 Chapter Organization 467 Part I: Theory 469 8.1 Certification Objectives and Processes 469 8.1.1 Certification, Standards and Definitions 470 8.2 Regulations, Standards and Organizations 474 8.2.1 Technical Standards for Medical Devices 477 8.2.2 European Context 478 8.3 Basic Protection Concepts 480 8.3.1 Protection Against Electric Shock 480 8.3.2 Insulation 484 8.3.3 Degree of Protection Provided by Enclosures 485 8.4 Verification of Constructional Requirements 486 8.4.1 Choice of Safety Critical Materials and Components 486 8.4.2 Creepage Distances and Air Clearances 489 8.4.3 Markings 490 8.4.4 Conductors 492 8.4.5 Connections to the Power Supply 494 8.4.6 Fire Enclosure 495 8.5 Medical Equipment Safety Tests 495 8.5.1 Leakage Current 497 8.5.2 Heating 499 8.5.3 Dielectric Strength 500 8.5.4 Stability and Mechanical Strength 500 8.5.5 Abnormal Operating and Fault Conditions 501 8.5.6 Continuity of Protective Earthing 502 8.5.7 Residual Voltage 503 8.5.8 Voltage on the Accessible Parts 503 8.5.9 Energy Stored – Pressurized Part 503 8.5.10 Current and Power Consumption 504 8.6 Electromagnetic Compatibility 504 8.6.1 Emissions 506 8.6.2 Immunity 511 8.6.3 The Test Report 513 Part II: Implementation 515 8.11 The Process 515 8.11.1 Device Description 516 8.11.2 Medical Device Classes 516 8.11.3 EU Conformity Assessment 519 8.11.4 Risk Management Deliverable 520 8.11.5 The Technical File 527 8.12 Regulatory Approaches to Medical Device Market Placement 537 8.13 Basic Concepts in Device Implementation 540 8.13.1 Protection Against Electric Shock 541 8.13.2 Insulation 541 8.13.3 Enclosure IP Protection 544 8.14 Verification on Design Performance 544 8.14.1 Safety-critical Materials 544 8.14.2 Creepage and Air Clearance 545 8.14.3 Other Verifications 545 8.15 Safety Tests 546 8.15.1 Leakage Current 546 8.15.2 Heating 546 8.15.3 Other Safety Tests 547 8.16 Electromagnetic Compatibility 548 8.16.1 Emission 549 8.16.2 Immunity 550 References 554 Summary of Regulations and Standards 555 Index 559

Read more less

Book SynopsisTable of ContentsForeword v Preface vi Dedications viii Part 1 Case histories 3 ECG interpretations and comments 53 Part 2 Case histories 83 ECG interpretations and comments 133 Appendix A: Differential Diagnoses 159 Appendix B: Commonly used abbreviations 161 Index 162

Read more less

Book Synopsis

Read more less

Book SynopsisNow there is an up-to-date guide for optimizing pharmacologic therapy in treating patients with heart failure. Reflecting current practice at leading medical centers, Heart Failure: Pharmacologic Management provides both the biologic and pathologic underpinnings of each pharmacologic agent in current use. It also supplies detailed discussions of the clinical investigations that support current understanding of the risks and benefits associated with the use of these drugs. Thorough references make the book useful to the novice as well as the experienced clinician. Initial chapters focus on agents that are considered standard care: diuretics ACE inhibitors angiotensin receptor antagonists aldosterone antagonists beta-blockers The discussion moves to agents currently Table of ContentsContributors. Introduction. 1. Diuretics in congestive heart failure (Alicia Ross, Ray E. Hershberger and David H. Ellison). 2. Use of digoxin in the treatment of heart failure (Deborah DeEugenio and Paul J. Mather). 3. Renin-angiotensin system and angiotensin converting enzyme inhibitors in chronic heart failure (Rimvida Obeleniene and Marrick Kukin). 4. Angiotensin receptor blockers in the treatment of hart failure (Anita Deswal and Douglas L. Mann). 5. Beta blockers (Peter F. Robinson and Michael R. Bristow). 6. Aldosterone antagonism in the pharmacological management of chronic heart failure (Biykem Bozkurt). 7. Inotropic therapy in clinical practice (Sharon Rubin and Theresa Pondok). 8. Antiarrhythmic therapy in heart failure (Igino Contrafatto and Leslie A. Saxon). 9. Treating the hypercoagulable state of heart failure: modifying the risk of arterial and venous thromboembolism (Geno J. Meril and Hoard H. Weitz). 10. Vasodilator and nitrates (Abdul Al-Hesayen and John D. Parker). 11. Natriuretic peptides fro the treatment of heart failure (Jonathan D. Sackner-Bernstein, Hal Skopicki and Keith D. Aaronson). 12. Immune modulatory therapies in heart failure: using myocarditis to gain mechanistic insights (Grace Chan, Koichi Fuse, Mei Sun, Bill Ayach and Peter P. Liu). 13. The role of vasopressin and vasopressin antagonists in heart failure (Olaf Hedrich, Maervin A. Konstam and James Eric Udelson). 14. Role of erythropoietin in the correction of anemia in patients with heart failure (Revecca P. Streeter and Donna M. Mancini). 15. Endothelin antagonism cardiovascular disease (Srinivas Murali). 16. Pharmacogenetics (Richard Sheppard and Dennis M. McNamara). 17. Management of diastolic dysfunction (Arthur M. Feldman and Bonita Fakner). 18. Multidrug pharmacy for treatment of heart failure: an algorithm for the clinician (Mariell Jessup). Index.

Read more less

Book SynopsisOffers a description of pacemaker ECG interpretations. This book includes: a refresher course on basic ECG interpretation with an overview of the conduction system of the heart; a review of the hardware associated with pacing; and, an explanation and discussion of the sensing and pacing function.Table of ContentsForeword. Preface. Acknowledgments. Section I - The Basics. Chapter 1. Basic ECG Refresher. Chapter 2. What Is a Pacemaker?. Chapter 3. Pacemaker System and Cardiac Anatomy. Chapter 4. The Hardware. The Pacemaker Generator. The Pacemaker Lead. The Pacemaker Programmer. The Pacemaker Magnet. Chapter 5. Electronics 101. The Electrogram. Chapter 6. Sensing and Sensitivity. Chapter 7. Pacing and Capture. Chapter 8. Rate Versus Interval. Chapter 9. The Code and Mode. Section II - The Modes. Chapter 10. VVI Pacing. VVI Timing. Rate Modulation. Magnet Mode (VOO). Chapter 11. AAI Pacing. AAI Timing. Rate Modulation. Magnet Mode (AOO). Chapter 12. DDD Pacing. DDD Timing. Upper Rate Behavior. Pacemaker-Mediated Tachycardia. Mode Switching. Rate Modulation. Magnet Mode (DOO). Chapter 13. VDD Pacing. VDD Timing. Upper Rate Behavior/Mode Switching. Magnet Mode (VOO). Chapter 14. DDI Pacing. DDI Timing. Rate Modulation. Magnet Mode (DOO). Chapter 15. DVI Pacing. DVI Timing. Rate Modulation. Magnet Mode (DOO). Section III - Unusual Pacing Situations and Alternate Applications of Permanent Pacing. Chapter 16. Unusual Pacing Situations. Diagnostic Pacing Modes. Pacing to Prevent Atrial Fibrillation. Transcutaneous Pacing. Automatic Threshold Determination. Diagnosis of Myocardial Infarction. Effects of Electric Cautery on Pacing. Chapter 17. Alternate Applications of Permanent Pacing. Pacing for Hypertrophic Obstructive Cardiomyopathy. Pacing for Ventricular Tachycardia. Pacing for Heart Failure. Pacing for Syncope. Section IV - Case Studies. Chapter 18. Case Studies Part A. Case Studies 1 - 7. Chapter 19. Case Studies Part B. Case Studies 8 - 43. Index

Read more less

Book SynopsisManagement of cardiovascular disease has changed dramatically, and the second edition of Primary Care Cardiology provides a comprehensive review of new treatment strategies. By emphasizing the basic principles critical to understanding and managing heart disease while putting recent developments in the field into perspective, this practical guide also serves as a curriculum for doctors studying for board examinations or re-certification. Helpful features include: Over 50 classic cardiovascular diagrams 50 summary tables for quick reference Concise overview of the vast body of cardiovascular literature Straightforward, readable tone Convenient pocket-size for rapid review Written for primary care physicians, this book is also perfect for physician assistants and nurse practitioners.Trade Review“I really cannot find many faults with this text. Primary Care Cardiology is a wonderful book to refresh your knowledge about cardiology. I would recommend it to anyone who has a desire to learn more about cardiology in a clinically relevant way. This book gives you practical knowledge and the applications of that knowledge.” – MD, Cardiology Fellow, Lubbock, Texas “I felt that the author provided clear, useful explanations for things that I have to date not heard explained so well, and I am continually impressed by the practical and applicable nature of the material covered in this text. It seems very relevant and appropriate for the primary care practitioner as well as the primary care PA/NP.” – RN, FNP, PA-C, Physician Assistant, La Jolla, California “Previously, I used multiple sources for all this information. Primary Care Cardiology compiles a lot of information in one volume that I haven’t seen pulled together in this same way before, and things are summarized in this text that I have not seen all in one source elsewhere. Overall, I think this book is an “A”!” - MD, MPH, Instructor-Fellow, Family Medicine/Pediatrics, Denver, Colorado “Primary Care Cardiology is a nice review of cardiovascular disease and the enormous literature that supports recent treatment recommendations. It seems like a practical guide for the majority of what one would encounter in the primary care setting. This is an important book that will serve as a nice brief review for the busy practitioner preparing for a board exam, or just searching to brush up on this critical topic.” – MD, MSc, Assistant Professor of Medicine, Kansas City, Kansas “Primary Care Cardiology is current and up-to-date. The author has been in clinical practice for many years and draws upon that valuable and relevant experience. He provides helpful examples from his own experience and validates his hypothesis with years of results, bridging the gap between theory and practical application very effectively. As I read the text I feel like I can trust the advice given.” – RN, FNP, PA-C, Physician Assistant, La Jolla, California “My overall impression of Primary Care Cardiology is that some valuable additions have been made to this book during the revision process. The information is up-to-date and concise. I especially appreciate the practical, less-formal tone.” – MD, MPH, Instructor-Fellow, Family Medicine/Pediatrics, Denver, Colorado “The main strength of the book is the way it simplifies topics in a way that makes them easy to understand without making you feel like you are reading a remedial text. The combination of the text and the figures really makes it easy to understand these difficult concepts. Taylor’s book could be read by anyone from a medical student or nurse to a practicing physician and be equally readable and helpful.” – MD, Cardiology Fellow, Lubbock, TexasTable of ContentsReviewers. Preface. Congestive Heart Failure Caused by Systolic Dysfunction Disorders of Ventricular Filling: Diastolic Heart Failure, Restrictive Cardiomyopathy, and Pericardial Disease Atherosclerosis: Mechanisms, Lipid Disorders, and Screening for Preclinical Disease Angina Pectoris: Evaluation of Chest Pain and the Management of Angina Pectoris and Acute Coronary Syndromes Myocardial Infarction Cardiac Arrhythmias and Syncope Valvular Heart Disease Hypertension, Aortic Disease and Other Medical Illnesses with Cardiovascular Effects Cardiology Consults: Preoperative Care of the Patient Having Noncardiac Surgery Isolated Right Heart Failure Congenital Heart Disease Seen in Adults Pregnancy and Heart Disease End-of-Life Decisions and Palliative Care for Patients with Heart Disease . Index

Read more less

Book SynopsisPresents a compendium of information regarding the complexities of clinical and genetic diagnosis, natural history, and management of hypertrophic cardiomyopathy (HCM) as well as related issues impacting the health of trained athletes. This book provides a single comprehensive source of information concerning HCM.Table of ContentsForewordPravin Shah, MD. Dedication and Acknowledgments. List of Contributors. 1. Phenotypic Expression and Clinical Course of Hypertrophic Cardiomyopathy. Barry J. Maron, MD2. Genetic Mutations that Remodel the Heart Carolyn Y. Ho, MD and Christine E. Seidman, MD. 3. Genetic Basis and Genotype-Phenotype Relationships in Familial Hypertrophic Cardiomyopathy. Albert A. Hagège, MD, PhD, Ketty Schwartz, PhD, Michel Desnos, MD, and Lucie Carrier, PhD. 4. Historical Perspective, Mechanism, and Clinical Significance of Left Ventricular Outflow Tract Obstruction in Hypertrophic CardiomyopathyMartin S. Maron, MD, Iacopo Olivotto, MD, and Barry J. Maron, MD. 5. Hypertrophic Cardiomyopathy with Latent (Provocable) Obstruction: Pathophysiology and Management. E. Douglas Wigle, MD, Maria Eriksson, MD, PhD, Paul Rakowski, David Focsaneanu, Cairrine Sloggett, RN, Anna Woo, MD, and Harry Rakowski, MD. 6. Pathophysiology and Clinical Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy. Iacopo Olivotto, MD, Barry J. Maron, MD, and Franco Cecchi, MD. 7. Other Modes of Disability or Death Including Stroke, and Treatment Strategies in Hypertrophic CardiomyopathyFranco Cecchi, MD, Iacopo Olivotto, MD, and Barry J. Maron, MD. 8. Disturbed Vascular Control in Hypertrophic Cardiomyopathy: Mechanisms and Clinical Significance. Ross Campbell, BSc, Jayne A. Morris-Thurgood, PhD, and Michael P. Frenneaux, FRCP, FRACP. 9. Clinical Significance of Diastolic Dysfunction and the Effect of Therapeutic Interventions. Sandro Betocchi, MD and Raffaella Lombardi, MD. 10. Value of Exercise Testing in Assessing Clinical State and Prognosis in Hypertrophic Cardiomyopathy. Sanjay Sharma, MRCP, MD. 11. Pathophysiology and Significance of Myocardial Ischemia in Hypertrophic Cardiomyopathy. Rajesh Thaman MBBS, MRCP, Bhavesh Sachdev MBBS, MRCP, and Perry M. Elliott MBBS, MD, MRCP. 12. Hypertrophic Cardiomyopathy in Japan: Clinical, Morphologic and Genetic Expression. Yoshinori Doi, MD, PhD, Hiroaki Kitaoka, MD, Nobuhiko Hitomi, MD, Naohito Yamasaki, MD, Yoshihisa Matsumura, MD, Takashi Furuno, MD, and Barry J. Maron, MD. 13. Prevalence, Prevention and Treatment of Infective Endocarditis in Hypertrophic CardiomyopathyPaolo Spirito, MD, Marco Piccininno, MD, and Camillo Autore, MD. 14. Pharmacologic Treatment of Symptomatic Hypertrophic CardiomyopathyMark V. Sherrid, MD and Ivan Barac, MD. 15. Obstructive Hypertrophic Cardiomyopathy: Results of Septal Myectomy Gordon K. Danielson, MD and Joseph A. Dearani, MD. 16. US Perspectives on the Role of Dual-Chamber Pacing in Patients with Hypertrophic CardiomyopathyPaul Sorajja, MD, Steve R. Ommen, MD, and Rick A. Nishimura, MD. 17. Dual-Chamber Pacing for Hypertrophic Obstructive Cardiomyopathy Xavier Jeanrenaud, MD, and Lukas Kappenberger, MD. 18. Alcohol Septal Ablation Hubert Seggewiss, MD Prof. Angelos Rigopoulos, MD, Lothar Faber, MD, and Peer Ziemssen, MD. 19. Alcohol Septal Ablation in the Treatment of Hypertrophic Obstructive Cardiomyopathy: A Seven-Year Experience. Horst Kuhn, MD, Thorsten Lawrenz, MD, Frank Lieder, MD, Frank H. Gietzen, MD, Ludger Obergassel, MD, Claudia Strunk-Muller, MD, Berit Stolle, MD, and Christian H. Leuner, MD. 20. Role of Septal Ablation in a Surgical CenterHarry M. Lever, MD. 21. Molecular and Clinical Tools for Sudden Death Risk Assessment in Hypertrophic Cardiomyopathy. Asifa Quraishi MB, MRCP, Mohammad S. Hamid MB, MRCP, and William J. McKenna MD, FRCP. 21A. In Memorium: Asifa Quraishi. 22. Risk Stratification For Sudden Death in Hypertrophic Cardiomyopathy: Extreme Left Ventricular Hyptertrophy as a New Indicator of Risk. Paolo Spirito, MD and Barry J. Maron, MD. 23. Implantable Defibrillator for Prevention of Sudden Death in Hypertrophic Cardiomyopathy. Barry J. Maron, MD, Win-Kuang Shen, MD, and Paolo Spirito, MD. 24. Hypertrophic Cardiomyopathy and Other Causes of Sudden Death in the Trained Athlete: An Electrophysiologist Perspective on the Management of Benign and Not So Benign Arrhythmias. N.A. Mark Estes III, MD, Paul J. Wang, MD, Munther K. Homoud, MD, and Mark S. Link, MD. 25. The Athlete’s Heart, the Athlete’s ECG, and Differential Diagnosis with HCM and Other Cardiomyopathies. Antonio Pelliccia, MD and Barry J. Maron, MD. 26. Importance of Congenital Coronary Artery AnomaliesCristina Basso, MD, PhD, Domenico Corrado, MD, and Gaetano Thiene, MD. 27. Arrhythmogenic Right Ventricular Cardiomyopathy and Hypertrophic Cardiomyopathy: Identification with the Italian Preparticipation Athlete Screening Program. Domenico Corrado, MD, Cristina Basso, MD, PhD, Maurizio Schiavon, MD, and Gaetano Thiene, MD. 28. Cardiovascular Causes of Sudden Death, Preparticipation Screening, and Criteria for Disqualification in Young AthletesBarry J. Maron, MD. 29.Sudden Death Due to Chest Blows (Commotio Cordis). Mark S. Link, MD, N. A. Mark Estes III, MD, and Barry J. Maron, MD. 30. Naturally Occurring Animal Models of Cardiovascular Disease Causing Premature Death. Philip R. Fox, DVM. 31. The Role of the Internet and Patient Support Groups for Those Living with Hypertrophic Cardiomyopathy. Lisa Salberg. AfterwordRobert Jon Pensack, MD. Index

Read more less

Book SynopsisThe rapidly growing population of adults surviving with congenital heart lesions along with the success of interventional cardiology in the child and adolescent has spawned an incredible interest in adapting the technology for the adult congenital patients. Dr. Mullins, a pioneer in this area, has written an outstanding reference which covers all aspects of performing diagnostic and therapeutic cardiac catheterization procedures on patients of all ages. This illustrated book details the equipment and techniques for performing safe and successful procedures, with a strong emphasis on avoiding complications. It also includes the requirements of a catheterization laboratory for congenital heart patients, as well as guidance for setting up and operating such a laboratory. Cardiac Catheterization in Congenital Heart Disease serves as an essential manual for pediatric and adult interventional cardiologists worldwide.Trade Review"This is an outstanding book in the field of congenital cardiac intervention, based on the 40-year experience of its author Dr Charles Mullins, a pioneer and leading figure in the field . . . I would strongly recommend this book as essential reading for all paediatric and adult congenital interventional cardiologists worldwide."Cardiology News, 1 October 2012 "The figures included in Cardiac Catheterization in Congenital Heart Disease reveal, in a simple yet powerful way, the basic strengths and characteristics of this long-awaited textbook from Charles Mullins. Line drawings demonstrating the intended course of needles, catheters, wires, and devices take the place of the fluoroscopic images and angiograms typically provided in catheterization textbooks. The idealization of these images is emblematic of the precision, deliberation, and attention to detail with which the author has approached catheterization of the child with congenital heart disease, an approach that has been successfully handed down to dozens of talented and dedicated trainees. ...Cardiac Catheterization in Congenital Heart Disease succeeds as a highly useful, instructive, and valuable textbook, largely as the result of Dr Mullins’s very personal view of his subject matter. In a field created and dominated by only a handful of leaders who have, in one fashion or another, trained almost all of the practitioners around the world, the publication of the experience that Dr Mullins gained over 40 years in the catheterization laboratory presents a milestone in pediatric interventional catheterization. This book codifies Dr. Mullins’s approach and provides, in a highly organized and readable format, a great deal of information relevant to pediatric interventional practice that has been, until now, passed through piecemeal reviews, book chapters, and much smaller, more focused textbooks. The 35 chapters dedicated to this small, highly specialized field with unique technical demands covers topics ranging from the optimal floor plan of a modern pediatric interventional catheterization laboratory, to the energy requirements for radiofrequency perforation of an atretic valve, to the precise method of handling guide wire positioning in the distal part of the circulation during balloon dilation and stent implantation. ...a comprehensive, detailed technical manual. The chapter on transcatheter atrial septal defect occlusion arms the interventional cardiologist with detailed knowledge of all the available occluding devices and the particular tricks for using each of these devices and delivery systems in a full 50 pages of text. Similar attention is paid to techniques and tools for obtaining vascular access and for performing balloon dilations. Although some of the very specific information provided will become obsolete rather quickly, points on the prioritization of balloon characteristics desirable for a particular intervention, or the general principles of wire placement and device handling will always remain relevant. As a technical manual, this text is extremely successful. ...this textbook will accomplish the author'’s goal of providing useful information to readers practicing at any level within the subspecialty field of pediatric interventional cardiology. To trainees and those recently entering the practice who may have had extensive exposure to pediatric interventional techniques but limited hands-on experience, this text will serve to solidify many of the concepts and common techniques used in the pediatric interventional laboratory. Advanced operators will use it as a reference and a technical narrative of minute details to aid in the planning of particular cases or in the management of infrequently encountered situations. As such, it is an enormously useful and long-awaited addition to the field of pediatric cardiology."—James E. Lock, MD; Audrey C. Marshall, MD, Children's Hospital, Boston, MA (Circulation, September 2006) "...a readily accessible, comprehensive, encyclopedically detailed compilationthat is both a reference book, and a working manual all in one volume. The book contains the most comprehensive details of catheter procedures, extending from vascular access and catheter manipulation, to the definition of cardiac structures displayed by specific radiographic views, the choice of views for specific diagnostic purposes, interpretation of hemodynamic and imaging data, and potential complications of catheterization, both diagnostic and interventional. The greatest strength of this book is certainly its comprehensiveness and detail. The information presented documents the author’s 40 years of pioneering experience in this field – a field that he has championed and led. Some of the information is not available from other sources - it does not lend itself well to journal publications. Most often, such information is handed down by word of mouth from the accomplished invasive cardiologist to the trainee at the cardiac catheterization table. The book should be available to every cardiologist seeking to hone his skills in specific techniques, and particularly trainees who are inexperienced in these procedures. Obviously, reading the text should complement 'hands-on' experience under the watchful eye of an experienced mentor – neither reading the text alone, nor performing procedures without the necessary knowledge, is acceptable. Reading should supplement the practice, and practice should consolidate the reading! This is, without doubt, the most valuable contribution this book can make. It is a vitally, fundamentally important contribution, regular reference to which will certainly enhance the safety and quality of cardiac catheterization procedures in patients with congenital heart disease. This is an excellent, comprehensive, well written resource, documenting a vast amount of practical information not available in any other single book. The material presented is based upon a lifetime of innovation, research, and practical experience of a master invasive cardiologist, and the information presented is authoritative, reliable, state-of-the-art and of inestimable value. It is a working manual that should be referred to constantly, repeatedly, and confidently. It is a book that is a niche resource, but that is its value. Indeed, in this regard, it is invaluable! It should be available to every invasive cardiologist faced with the complexity of congenital heart disease in children or adults. For this purpose, I recommend it with full confidence and enthusiasm."Journal of Interventional Cardiology, June 2006 "Cardiac Catheterization in Congenital Heart Disease is an outstanding textbook based on the experience and practice of the author during four decades of work in the Catheterization Laboratory at the Baylor College of Medicine, Texas Children's Hospital, and who has been an innovator and leader in the field of cardiac catheterization in congenital heart disease for those 40 years. Not only has Dr. Charles Mullins been one of the major innovators for all aspects of cardiac catheterization techniques, but he has also taught and trained hundreds of individuals who utilize his experience in techniques to do cardiac catheterizations around the world. There is no single individual who has influenced the cardiac catheterization field in congenital heart disease as much as Dr. Mullins. As Dr. Mullins says, this text emphasizes “the minute details and fundamentals of catheterization procedure”. His attention to the smallest detail in both practice and innovation is truly the reason he has been so successful over the years. The book is divided nicely and in a very readable way. The first chapters deal with organization of the catheterization laboratory, medications used, patient preparation, equipment, needles and vascular access with great drawings depicting how one actually does the techniques, catheter manipulations with again precise drawings and explanations of how actually to manipulate the catheter. One of the problems with other textbooks on cardiac catheterization is the lack of precise detail for readers, students, residents, fellows, and other physicians, about how actually to move the catheter to get it into certain positions. The chapter on catheter manipulation is superb. Other chapters involve guidewires, flow-directed catheters, certain techniques such as transseptal approaches, and an excellent chapter on retrograde cardiac catheterization. There is also an excellent chapter going over in detail on two neglected areas of: Catheterization: (1) hemodynamics, dye curves, data recording and (2) angiographic techniques. Dr. Mullins then goes into specific interventional catheterization techniques, such as atrial septostomies, septectomy, balloon dilatation, mitral valvuloplasty, coarctation dilatation branch pulmonary artery and pulmonary artery stenosis dilatations, and intervascular stents. The last part of the textbook is focused on individual congenital heart lesions, such as patent ductus arteriosis, atrial septal defect, patent foramen ovale, ventricular septal defect, transplant endomyocardial biopsy, and the techniques utilized to address those particular defects with, again, outstanding illustrations and explanations of the manipulations involved. This text is a 'must' in the library of anyone who deals with any aspect of congenital heart disease, whether that is pediatric or adult congenital heart disease, clinical care, congenital cardiac nursing, or congenital cardiac surgery. It is the accumulation of an individual’s experience, wisdom, and knowledge over 40 years as these techniques have evolved, and of an individual who has been at the forefront of the development and creative implementation of all areas of cardiac catheterization as it relates to congenital heart disease. It is a superb textbook and a tribute to the talent, experience, and wisdom of an individual and an institution that have made great contributions to congenital heart disease over the past 35 years."Congenital Heart Disease, May 2006 "Cardiac Catheterization in Congenital Heart Disease: Pediatric and Adult is an exceptional book!.... It is without doubt the most authoritative, the most comprehensive and the most detailed textbook about cardiac catheterization in congenital heart disease ever published.... Each chapter is well-referenced. Unlike most familiar texts of this magnitude, Dr. Mullins wrote every chapter and every word. This is all his work.... Any cardiologist seeking education or information about venous stenting, need only study this one source.... It is obvious that with this book, Dr. Mullins gives each of us a gift. In the Preface he tells us that 'the information contained in this text...represents the accumulation of knowledge, techniques, and procedures learned, utilized and/or developed by the author during the continued learning, practice and teaching, of cardiac catheterization procedures during...four decades in the field."Congenital Cardiology Today, January 2006Table of ContentsPreface. Dedication. Introduction. 1 Organization of a pediatric/congenital cardiac catheterization laboratory. 2 Medications used in or in conjunction with the cardiac catheterization laboratory and patient preparation for cardiac catheterization. 3 Cardiac catheterization equipment. 4 Vascular access: needle, wire, sheath/dilator and catheter introduction. 5 Catheter manipulations. 6 Special guide and deflector wires and techniques for their use. 7 Flow directed catheters (“floating” balloon catheters). 8 Transseptal left heart catheterization. 9 Retrograde arterial cardiac catheterization. 10 Hemodynamics, data acquisition, and interpretation and presentation of data. 11 Angiographic techniques. 12 Foreign body removal. 13 Balloon atrial septostomy. 14 Blade/balloon atrial septostomy, special atrial septostomies, atrial “stent septostomy”. 15 Balloon dilation proceduresageneral. 16 Pulmonary valve balloon dilation. 17 Dilation of branch pulmonary artery stenosis. 18 Dilation of coarctation of the aortaanative and re/residual coarctation. 19 Aortic valve dilation. 20 Mitral valvuloplasty. 21 Dilation of tricuspid valve stenosis, systemic vein stenosis and miscellaneous intravascular/intracardiac stenoses. 22 Intravascular stents in congenital heart diseaseageneral considerations, equipment. 23 Intravascular stent implantapulmonary branch stenosis. 24 Intravascular stents in venous stenosis. 25 Coarctation of the aorta and miscellaneous arterial stents. 26 Occlusion of abnormal small vessels, persistent shunts, vascular fistulae including perivalvular leaks. 27 Transcatheter occlusion of the patent ductus arteriosus (PDA). 28 Transcatheter atrial septal defect (ASD) occlusion. 29 Occlusion of the patent foramen ovale (PFO), atrial baffle fenestrations and miscellaneous intracavitary communications. 30 Transcatheter closure of ventricular septal defects. 31 Purposeful perforation of atretic valves, other intravascular structures and recanalization of totally obstructed vessels. 32 Special innovative or new, therapeutic catheterization procedures and devices. 33 Endomyocardial biopsy. 34 Phlebotomy, pericardial and pleural drainage. 35 Complications of diagnostic and therapeutic cardiac catheterizations. Index

Read more less

Book SynopsisProviding optimal care for heart failure patients is a complex challenge that requires cooperation and coordination across multiple disciplines. Now, you can apply the successful techniques pioneered at the Cleveland Clinic, which are carefully explored and explained in this text. Drs. McCarthy and Young draw on their experience to show how an interdisciplinary team works together to: arrive at a proper diagnosis initiate medical therapy make decisions regarding the best use of percutaneous therapies, surgical therapies, electrical therapies, and the use of mechanical circulatory support devices and transplantation. Throughout the book, they present the most updated evidence for both drug trials and surgical trials. They emphasize the benefits of performing the most complete surgery that is practical, then continuing medical therapy. Each chapter focuses on one aspect of treatment, but the authors recognize that the best way to manage anTrade Review“This first edition is an excellent review of the modern management of heart failure…well organized, succinct, and elegantly reviews the current modalities.” Doody’s Review Service"This first edition is an excellent review of the modern management of heart failure written by specialists from multiple disciplines. It is well organized, succinct, and elegantly reviews the current modalities in the treatment of heart failure." (Bijesh P. Maroo, BS, MS, MD, @Doody's Review Service)Table of ContentsList of Contributors, vii Preface, ix Acknowledgements, xi 1 Epidemiology of heart failure: progression to pandemic?, 1 Randall C. Starling 2 Heart failure clinical trials: shaping the evidence for treatment guidelines, 9 James B. Young 3 Standard medical therapy of heart failure, 21 Mohamad H. Yamani 4 Novel therapies in heart failure, 44 W.H.Wilson Tang & Gary S. Francis 5 Implantable cardioverter defibrillators and biventricular pacemakers in congestive heart failure, 69 Mandeep Bhargava & Bruce L.Wilkoff 6 Managing a heart failure clinic, 99 Nancy M. Albert 7 Novel imaging technologies for heart failure patients, 115 Richard D. White 8 Assessment of myocardial viability in ischemic cardiomyopathy, 126 Raymond Q.Migrino 9 Bypass surgery in the treatment of ischemic cardiomyopathy, 145 Bruce W. Lytle 10 Valve surgery for patients with left ventricular dysfunction, 153 Patrick M.McCarthy 11 Ventricular reconstruction and device therapies for cardiomyopathy patients, 174 Patrick M.McCarthy & Edwin C.McGee, Jr. 12 Mechanical circulatory support, 192 José Luis Navia 13 The role of heart transplantation, 228 David O. Taylor 14 Perioperative care of the surgical patient with heart failure: from conventional cardiac surgery to mechanical circulatory support, 255 Tiffany Buda & Patrick M.McCarthy 15 Biological approaches to heart failure: gene transfer and cell transplantation, 272 Marc S. Penn, Samuel Unzek & Arman T. Askari 16 Ethical issues in cardiothoracic medicine, 289 Katrina A. Bramstedt Disclosure Statements, 305 Index, 307

Read more less

Book Synopsis* Includes material by an internationally renowned group of authorities directed by a prominent member of the faculty of the Mayo Clinic * The contents represent a well-balanced clinical endovascular approach to the exciting area of vascular medicine and surgery.Table of ContentsContributors. Acknowledgements. Introduction.. Part I: Preoperative and Operative Considerations. 1. Long-term outcome following open repair of abdominal aortic aneurysms (Audra A. Noel). 2. Durability of Endovascular repair of infrarenal aortoiliac aneurysms: what lessons have been learned (Josef Klocker and Albert G. Hakaim). 3. Imaging techniques and protocols for endovascular repair of abdominal aortic aneurysms (Ricardo Paz-Fumagalli J. Mark Mckinney, and Andrew H. Stockland). 4. Essential operating room equipment, personnel, and catheter inventory for endovascular repair of abdominal aortic aneurysms (Peter A. Schneider and Michael T. Caps). 5. Essential interventional suite design, equipment, personnel, and catheter inventory for endovascular repair of abdominal aortic aneurysms (Eric Huettl, William M. Stone, and Richard J. Fowl). 6. Diagnosis, management, and prevention of atheroembolization and contrast media-induced renal insufficiency during endovascular repair of abdominal aortic aneurysms (Andrew Wasiluk and William E. Haley). 7. Anesthetic management for endovascular repair of abdominal aortic aneurysms (Monica Myers Mordecai, Perry S. Bechtle, and Bruce J. Leone). Part II: Commercially available stent graft systems. 8. Commercially available endovascular stent grafts (Timothy A. Hipp and Albert G. Hakaim). 9. Ancure endograft (Thomas C. Noslund). 10. AneuRx stent graft system (John W. York and Samuel R. Money). 11. Excluder bifurcated endoprosthesis system (Eric T. Choi and Gregorio A. Sicard). 12. Zenith AAA endovascular graft (Beate Neuhauser, W. Andrew Oldenburg, and Albert G. Hakaim). 13. PowerLink stent graft system (Edward B. Diethrich). Part III: Investigational Stent Graft Devices. 14. Lifepath AAA bifurcated graft system Sashi Kilaru and K. Craig Kent). 15. Talent LPS endoluminal stent graft (Sherry D. Scovell, Lisa Jordan, and Roy K. Greenberg). 16. Balloon-expendable stent and polytef-based endograft for repair of complex and ruptured abdominal aortic aneurysms (Takao Ohki and Frank J. Veith). 17. Custom Dacron-stainless steel stent grafts (Albert G. Hadaim and Timothy M. Schmitt). Part IV: Intraoperative ancillary procedures. 18. Use of intravascular ultrasonography in endovascular intervention (Jonathan D. Woody, George E. Kopchok, James T. Lee, and Rodney A. White). 19. Intentional occlusion of the internal iliac artery to facilitate endovasuclar repair of aortoiliac aneurysms (Alfio Carroccio, Peter L. Faries, MIchael L. Martin, Osvaldo Juniti Yano, adn Larry H. Hollier). 20. Arterial access for endovascular aneurysm repair (Timothy A.M. Chuter). 21. Ancillary interventions to provide proximal and distal endograft fixation (L. Louis Lau, and Albert G. Hakaim). 22. Prevention, diagnosis, and management of endoleaks (Srinivasa Rao Vallabhaneni, Martin Malina , Bjorn Sonesson, and Krassi Ivancev). Part V: Appendix. Reporting standards for endovascular aneurysm repair (Albert G. Hakaim). Index.

Read more less

Book SynopsisPathology of Sudden Cardiac Death provides a comprehensive review of cardiovascular disorders. While sudden cardiac death could primarily be seen as an arrhythmogenic event, this actually represents the minority of cases. For the vast majority, there is an underlying anatomic disorder of the cardiovascular system responsible for the ultimate hemodynamic collapse known as sudden cardiac death. Although an increasing array of non-invasive diagnostic tools continue to develop, many physicians and operators of these new diagnostic modalities have never actually seen specimens which demonstrate the fundamental pathologic abnormalities. By providing an atlas style review of ischemic and non-ischemic etiologies of sudden cardiac death, this book opens a window to see the underlying pathology first hand.Table of ContentsPreface. Foreword. Introduction. Acknowledgments. 1. Atherosclerotic coronary disease. 2. Nonatherosclerotic coronary disease. 3. Myocardial disease. 4. Diseases of the conduction system. 5. Systemic hypertension. 6. Valvular heart disease. 7. Metabolic and infiltrative disorders. 8. Tumors and blood dyscrasias. 9. Great vessels and related structures. 10. Diseases of the pericardium. 11. Multi-organ system diseases. References. Index.

Read more less

Book SynopsisNew Arrhythmia Technologies provides a complete discussion of recent, emerging, and future arrhythmia technologies. This forward-thinking book details successful trials and investigates areas of research that have not yet reached the trial phase.Table of ContentsList of Contributors. Preface. Section I Advances in Antiarrhythmic Pharmacologic Therapy. Chapter 1 New Antiarrhythmic Pharmacologic Therapies and Regulatory Issues in Antiarrhythmic Drug Development. Chapter 2 New Frontiers in Antithrombotic Therapy for Atrial Fibrillation. . Section II Future of Antiarrhythmic Therapy. . Chapter 3 Principles of Pharmacogenomics: Focus on Arrhythmias. Chapter 4The Cardiac Sodium Channel Carboxy Terminus: Predicted and Detected Structure Provide a Novel Target for Antiarrhythmic Drug Development. Chapter 5Embryonic stem cell-derived cardiomyocytes as a model for arrhythmia. Chapter 6Gene and Cell Therapy for Sinus and AV Nodal Dysfunction. Chapter 7Gene Therapy for Cardiac Tachyarrhythmias. Section III Monitoring, Noninvasive Mapping, Risk Assessment, and External Defibrillation. Chapter 8 New Developments in Noninvasive Rhythm Monitoring, Implantable Hemodynamic, Monitoring, Functional Status Monitoring ,and Non-Invasive Mapping. Chapter 9Techniques of Prediction of Arrhythmia Occurrence and Stratification for Sudden Cardiac Death. Chapter 10 Beta-blocker Efficacy in Long QT Syndrome Patients with Mutations in the Pore and Nonpore Regions of the hERG Potassium-channel Gene. Chapter 11 New Developments in Out-of-Hospital Cardiac Defibrillation. Section IV Advances in Pacing. Chapter 12 Sensor and Sensor Algorithms. Chapter 13New Electrode and Lead Designs for Pacemakers. Chapter 14Current Concepts in Intravascular Pacemaker and Defibrillator Lead Extraction. Chapter 15Left Ventricular Epicardial Lead Implantation: Anatomy, Techniques, and Tools. Chapter 16New Resynchronization Lead Systems and Devices. Chapter 17New Indications for Pacing. Section V Advances in Implantable Defibrillators. Chapter 18New Sensing and Discrimination Algorithms. Chapter 19Arrhythmia Prevention and Termination Algorithms. Chapter 20New Lead Designs and Lead-Less Systems. Chapter 21Optimization of Defibrillation Function. Chapter 22Remote Web-Based Device Monitoring. Chapter 23New ICD Indications. Section VI Advances in Catheter and Surgical Ablation. Chapter 24Advances in Surgical Ablation Devices for Atrial Fibrillation. Chapter 25Epicardial Access. Chapter 26Advances in Catheter Control Devices. Chapter 27Advances in Energy Sources in Catheter Ablation. Chapter 28New Ablation Paradigms: Anatomic Ablation of Complex Arrhythmia Substrates. Index

Read more less

Book SynopsisVariants of Ventricular Preexcitation: Recognition and Treatment provides a unique opportunity for general cardiologists and electrophysiologists to find in one text the intricacies of recognizing and treating a group of disorders that has intrigued physicians for more than 100 years.from the Foreword by Mark E. Josephson, MD, Chief, Cardiovascular Division, Beth Israel Deaconess Medical Center, Boston, USA Drs Sternick and Wellens combine their expertise in the diagnosis and treatment of cardiac arrhythmias to bring you this complete overview of decrementally conducting accessory pathways and their role in cardiac arrhythmias. This is the first book dedicated to these special types of accessory pathways, their recognition and management. By covering the uncommon varieties of ventricular preexcitation, this book supports you in improving patient care by: Helping you to identify decrementally conducting AV fibers- which comprise 3-5 % ofTable of ContentsForeword vii Acknowledgements ix 1 Historical notes and classification of the variants of ventricular preexcitation 1 2 The anatomy of decrementally conducting fibers 7 3 Atriofascicular pathways and decrementally conducting long atrioventricular pathways 15 4 The short AV decrementally conducting fibers 59 5 Nodoventricular and Nodofascicular fibers 75 6 Fasciculoventricular fibers 83 7 Conduction disturbances in accessory pathways 103 8 Automaticity in decrementally conducting fibers 117 9 Differential diagnosis of left bundle branch block-shaped tachycardias 131 Index 149 A colour plate section faces p. 22

Read more less

Book SynopsisCardiovascular Risk Management Edited by Professor Richard Hobbs, University of Birmingham.Trade Review"An updated text, which has the merit of taking stock of the situation in a field, the management of cardiovascular risk, where the fast and sudden classification of the patient is essential . . . In conclusion, the work is properly addressed to all those who wish to have an overview of the management of patients at risk for cardiovascular disease, including nuclear physicians involved in nuclear cardiology." (Eur J Nucl Med Mol Imaging, 2010) "This is an extremely valuable book for practicing physicians and researchers of cardiovascular disease. I highly recommend it for every medical library.” (Doody's Reviews, May 2009)Table of ContentsForeword. Contributors. 1. The epidemiology of cardiovascular disease. 2. Using guidelines as a framework for cardiovascular risk management: comparison of international recommendations. 3. Identifying high-risk patients. 4. Moderate- to low-risk patients: management recommendations. 5. High-risk patients: management recommendations. 6. Type 2 diabetes and metabolic syndrome patients: management recommendations for reducing cardiovascular risk. 7. Lifestyle changes to reduce cardiovascular risk. 8. Pharmacotherapy: improving the lipid profile. 9. Pharmacotherapy: lowering blood pressure. 10. Pharmacotherapy: lowering blood glucose. 11. Long-term management of cardiovascular disease. 12. Managing cardiovascular risk in the future. Appendix. Index.

Read more less

Book SynopsisThis guide to the proper use of the ECG in diagnosing acute myocardial infarction puts the combined experience of international authorities at your fingertips for immediate use. In The 12 Lead ECG in ST Elevation MI: A Practical Approach for Clinicians, Drs. Bayés de Luna, Fiol-Sala and Antman supply the practical, specific information you need to determine which patients with ACS are showing ST elevation. To facilitate correct diagnosis and guide management, the authors use a consistent sequence to explain the ECG abnormalities for each site of coronary occlusion. A schematic of the coronary tree illustrates the point of occlusion. The second part of the book contains a self-assessment section with a series of 15 cases, each of which includes one or more 12-lead ECGs for analysis. These valuable examples help you prepare for on-the-spot interpretation in the emergency department or intensive care unit.Table of ContentsForeword. Introduction. 1 The heart walls and coronary circulation. The heart walls and their segmentation: The importance of uniform nomenclature. Coronary circulation: The perfusion of the heart walls. 2 The ECG changes in ST elevation myocardial infarction. 3 The concept of injury vector: direct and reciprocal patterns. 4 Clinical interpretation and significance of ST changes. Location of the occlusion and risk stratification: the role of deviations of the ST-segment. 1. From the occluded artery to the area at risk and thecorresponding electrocardiographic abnormality. 2. From the electrocardiographic pattern to the occluded artery and the area at risk. Other characteristics of ST elevation regarding prognosis. ST changes in patients with ischemia due to multivessel occlusion. 5 Conclusions. 6 Self-assessment. References. Index.

Read more less

Book Synopsis. . . every critical examination of HF therapy in the United States has documented that we are not using all the weapons in our arsenal. We know what works, yet we are not systematically applying these proven therapies.from the Introduction If you are interested in a better way to treat heart failure, this book is for you. Dr. Michael McIvor who has taught thousands of healthcare professionals how to effectively care for patients with chronic HF through CME symposia takes a logical, step-by-step approach to setting up and operating the kind of program that reduces hospital admissions and improves patient care. Establishing a Heart Failure Program: The Essential Guide answers the different questions posed by physicians, nurse practitioners, nurses, and hospital administrators, all of whom need to work as a team to achieve success. The three major sections of the book address: Taking the first steps toward building your heart faiTable of ContentsAcknowledgments vii Introduction ix Companion Website xii 1 Is a heart failure program the right choice? 1 2 A formula for the success of your heart failure program 9 Section I Taking the first steps toward building your heart failure program 3 First steps: a business plan for your heart failure program 21 4 First steps: choosing your model of care 33 5 First steps: a global view of the financial projections for your heart failure program 47 6 First steps: a heart failure program pro forma 61 Section II Assembling the pieces of your program 7 Assembling the pieces: the managers of your program 75 8 Assembling the pieces: the front line staff 83 9 Assembling the pieces: the physical facility 89 Section III Day-to-day operations 10 Baseline assessments 95 11 Heart failure clinic follow up visits 111 12 Medical treatment protocols 123 13 Telemanagement algorithms 135 14 Advanced therapies 143 15 Positioning your heart failure program as a center of expertise 149 Index 155 About the author 161

Read more less

Book SynopsisCardiology: Clinical Cases Uncovered is the ideal integrated text to help you recognize, understand and know how to investigate and manage many heart-related disorders and conditions. Written by three practising cardiologists,itleads students through a clinical approach to managing problems with 26 real-world cardiovascular cases. There is strong emphasis on high-quality figures, particularly 12-lead ECGs, as these play such a major role in the evaluation of the cardiac patient. Following a question-answer approach throughout the narrative, with self-assessment MCQs, EMQs and SAQs, Cardiology: Clinical Cases Uncovered includes sections on cardiac anatomy, physiology and pathology which provide the essentials required to understand clinical cardiology, and is ideal for medical students and junior doctors on the Foundation Programme, specialist nurses and nurse practitioners, and for those with plans for a career in cardiology.Trade Review"The authors should be congratulated for providing comprehensive case scenarios aiding ‘decision making' skills and for exploring and covering so much material in such a small volume. A ‘must read' for trainees!." (Cardiology News, 1 October 2011) "This excellent text is likely to become popular with students and cardiologists in training." (Journal of Tropical Pediatrics, 1 April 2011) "This excellent text is likely to become popular with students and cardiologists in training." (Journal of Tropical Pediatrics, 14 October 2009) "Of note are the illustrations, in basic colour, and some of the clearest I've seen for some time." (British Journal of Cardiac Nursing, June 2010)Table of ContentsPreface, vii How to use this book, viii List of abbreviations, ix Part 1 Basics, 1 Basic science, 1 Approach to the patient, 23 Part 2 Cases, 38 Case 1 A 47-year-old man with chest pain, 38 Case 2 A 60-year-old heavy goods vehicle (HGV) driver with chest pain, 48 Case 3 An 85-year-old man with collapse, 56 Case 4 A 71-year-old man with exertion chest tightness, 63 Case 5 A 50-year-old man with sudden-onset severe central chest pain, 72 Case 6 A 45-year-old man with chest pain and breathlessness, 77 Case 7 A 34-year-old man with chest pain following a viral illness, 84 Case 8 An 80-year-old woman with acute severe breathlessness, 90 Case 9 A 50-year-old man with exertional breathlessness, 98 Case 10 A 72-year-old woman with breathlessness on exertion, 107 Case 11 A 50-year-old man with a murmur, 112 Case 12 A 30-year-old man with high blood pressure and a heart murmur, 118 Case 13 A 64-year-old man with collapse and a murmur, 124 Case 14 A 34-year-old man with malaise, chest pains and breathlessness, 130 Case 15 A 22-year-old woman with faints, 136 Case 16 A 76-year-old woman with blackouts, 142 Case 17 A 35-year-old woman with palpitations, 148 Case 18 A 42-year-old man with palpitations, 153 Case 19 A 64-year-old man with fatigue and palpitations, 160 Case 20 A 24-year-old man with palpitations, 165 Case 21 A 77-year-old woman with fatigue and bradycardia, 171 Case 22 A 57-year-old man with collapse, 177 Case 23 A 36-year-old woman with a family history of sudden death, 183 Case 24 A 60-year-old man with high blood pressure, 190 Case 25 A 24-year-old woman with visual loss and dysphasia, 196 Case 26 A 59-year-old woman with low blood pressure and breathlessness, 202 Part 3 Self-assessment, 208 MCQs, 208 EMQs, 214 SAQs, 224 Answers, 228 Index of cases by diagnosis, 235 Index, 237

Read more less

Book SynopsisThis new reference guides physicians in the practical aspects of how to diagnose and treat patients with congenital heart disease.Table of ContentsContributors vii Preface xi Foreword xiii 1 Secundum atrial septal defect 1Sabrina D. Phillips 2 Atrioventricular septal defects 9Frank Cetta 3 Pulmonary stenosis/right ventricular outflow tract obstruction 25Elyse Foster and Katy Lease 4 Ventricular septal defect 41Naser M. Ammash 5 Pulmonary arterial hypertension in Eisenmenger Syndrome 57Kevin Owusu-Ansah, Zeksen Lim and Gruschen R. Veldtman 6 Congenitally corrected transposition of the great arteries 76Sara A. Thorne 7 Left ventricular outflow tract obstruction 87Craig S. Broberg 8 Coarctation of the aorta and aortic disease 102Michelle Z. Gurvitz 9 Transposition of the great arteries after a Mustard atrial switch procedure 126Folkert Meijboom and Gary Webb 10 Tetralogy of Fallot 139Judith Therrien 11 Single ventricle physiology 157Michael A. Gatzoulis and Lorna Swan 12 Ebstein’s anomaly 174Heidi M. Connolly 13 Imaging in adult congenital heart disease 190Candice K. Silversides and Samuel C. Siu 14 The chest x-ray in congenital heart disease 208Joseph K. Perloff 15 Arrhythmias in congenital heart disease 221Barbara J. Deal 16 Pregnancy and contraception 237Rachel M. Wald and Jack M. Colman Index 260 Author Disclosure Table 272

Read more less

Book SynopsisThis book is part of the AHA Clinical Series published in conjunction with the American Heart Association in order to focus on high-interest and emerging topics in cardiovascular disease targeted for cardiologists and other interested healthcare providers.Table of Contents1. Risk Factors, diagnosis and epidemiology. 2. Pathophysiology (iatrogenic shock, peripheral circulation). 3. General Management. a. Inotropes / Vasopressors. b. Mechanical Ventilators. c. Other Medications. 4. Pump failure - Left Ventricular. 5. Pathophysiology and management of right heart ischemia. 6. Ventricular septal rupture and tamponade. 7. Mitral regurgitation and valvular disease. 8. Cardiogenic shock in other heart diseases: acute decompensation of chronic heart failure, myocarditis, transient apical ballooning syndrome, peripartum cardiomyopathy, hypertrophic cardiomyopathy, and chronic valvular stenosis. 9. Circulatory support devices. 10. PCI (including post CABG). 11. CABG

Read more less

Book SynopsisThe relationship of metabolic diseases to cardiovascular disease (CVD) is reaching epidemic proportions. This relates mostly to the increasing prevalence of obesity, the metabolic syndrome and type 2 diabetes.Trade Review"This book gives a clear overview of metabolic risk factors associated with cardiovascular risk, along with risk reduction strategies." (Doody's, 14 October 2011) Table of ContentsContributors. Foreword. 1 Insulin action and beta-cell function: role in metabolic regulation (Kristina M. Utzschneider and Steven E. Kahn). 2 Lipid and lipoprotein metabolism, and risk for cardiovascular disease (Frank M. Sacks). 3 Tobacco and risk for cardiovascular disease (C. Barr Taylor and Mickey Trockel). 4 Nutrition and risk for cardiovascular disease (Alice H. Lichtenstein). 5 Physical activity and cardiovascular health (William E. Kraus and William L. Haskell). 6 The obesity epidemic and cardiovascular risk (Paul Poirier). 7 Insulin resistance, the metabolic syndrome, and cardiovascular risk (Stanley S. Wang and Sidney C. Smith, Jr). 8 Diabetes mellitus and cardiovascular risk (Peter W. F. Wilson). 9 Lipid management and cardiovascular risk reduction (Antonio M. Gotto, Jr. and John A. Farmer). 10 Obesity management and cardiovascular risk reduction (George A. Bray). 11 Diabetes management and cardiovascular risk reduction (Jay S. Skyler). 12 A healthy lifestyle and cardiovascular risk reduction (Arne V. Astrup). Index. Author Disclosure Table.

Read more less

Book SynopsisECGs for Nurses provides everything the nurse needs to know about the electrocardiogram. Accessible yet comprehensive, and packed with case studies, this portable guide enables nurses to become skilled practitioners in an area often seen as highly complex. Using real ECG traces as examples, possible effects on the patient and treatment options are discussed, with a focus on the role of the nurse. This fully illustrated second edition remains the essential reference guide for nurses working in all acute areas, as well as general nurses and students learning about ECGs for the first time. One of the only ECG texts written by a nurse specifically for nurses Written by an expert in the field Easy-to-access information, full of practical advice Essential for nurses working and studying in intensive care, high dependency units, theatre, theatre recovery coronary care units, medical wards and accident and emergency. Case studies and discussTrade Review"I thoroughly recommend this text to all who work within an acute care area, or indeed any nurse with an interest in developing their ECG interpretation skills."--British Journal of Resuscitation "Easy to read, succinct review of the cardiac conduction system...(a) useful tool for any health professional new to a monitored environment, and would provide the essential baseline knowledge required for such staff."--British Journal of Perioperative Nursing Table of ContentsForeword iv Acknowledgements vi Chapter 1 The conduction system in the heart 1 Chapter 2 Principles of ECG monitoring 10 Chapter 3 ECG interpretation of cardiac arrhythmias 40 Chapter 4 Cardiac arrhythmias originating in the SA node 50 Chapter 5 Cardiac arrhythmias originating in the atria 72 Chapter 6 Cardiac arrhythmias originating in the AV junction 96 Chapter 7 Cardiac arrhythmias originating in the ventricles 114 Chapter 8 Cardiac arrhythmias with atrioventricular block 135 Chapter 9 Cardiac arrhythmias associated with cardiac arrest 155 Chapter 10 Recording a 12 lead ECG 169 Chapter 11 Interpreting a 12 lead ECG 182 Chapter 12 Management of peri-arrest arrhythmias 220 Chapter 13 Record keeping 243 Appendix 249 Index 286

Read more less